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ABSTRACT 
The endocrine system refers to glands which secrets hormones that regulates a variety of 
physiological processes. The adrenal cortex is part of the endocrine hypothalamus-pituitary-
adrenal axis, and produces and secretes steroids regulating stress reactions after stimulation by 
hormones secreted from the brain. Being an organ regulated by hormones, the adrenal cortex is 
also a potential a target for endocrine disrupting compounds that may mimic endogenous 
hormone receptor ligands. The Y1 adrenocortical cell line is an in vitro model originating from 
a tumour in the mouse adrenal cortex, and has maintained the ability to produce and secrete 
steroids. In this thesis, Y1 cells were exposed to a complex mixture of persistent organic 
pollutants (POPs), and the effects on steroidogenesis on steroid production and selected 
steroidogenic enzymes were studied with LC-MS/MS and Western blotting, respectively. 
Results showed that the overall steroid production in the cells was increased in the highest 
administered dose of the POP mixture. This indicates that POPs present in the mixture could 
act as endocrine disruptors and alter the steroidogenesis. More studies of the effects of this 
mixture might provide more information of the mechanisms behind increased steroidogenesis.   
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1. INTRODUCTION 
1.1 The adrenal endocrine system  
The endocrine system refers to glands which secrets hormones that regulates a variety 
of physiological processes. The adrenal gland is part of the endocrine system, and consists of 
the adrenal medulla and the adrenal cortex. The adrenal medulla secretes catecholamines like 
adrenaline and norephineprine in an immediate acute stress stimulation known as the fight-or-
flight response. This is a nerve response regulated by the sympathetic nervous system (SNS). 
The adrenal cortex is part of the endocrine hypothalamus-pituitary-adrenal axis, and produces 
and secretes steroids regulating stress reactions after stimulation by hormones secreted from 
the brain (Rainey et al., 2004).  
One way of defining stress is describing it as a state of threatened homeostasis, harmony, 
balance, or equilibrium (Johnson et al., 1992). A stressor may be internal factors like 
hypoglycaemia, or factors such as temperature, exercise or injury, or psychological factors that 
give rise to fear or anxiety (Johnson et al., 1992). One of the major ways of coping with stress 
in humans and other animals is the involvement of the hypothalamic-pituitary-adrenal (HPA) 
axis (Dedovic et al., 2009). This axis releases specific hormones from the brain that are 
transported to the adrenal gland, which produce glucocorticoids, mineralocorticoids and sex 
steroids from cholesterol. This axis is a vital part of maintaining homeostasis under normal 
basal conditions, as well as when a person or animal is faced with a stress factor or stressor.  
Glucocorticoids produced in the adrenal cortex are transported to various organs throughout the 
body, which then binds to glucocorticoid receptors. Glucocorticoid receptors are found in many 
cell types in several organs and the brain, and can modify the transcription of key regulatory 
proteins (Herman et al., 2003). The effect of glucocorticoids in the organism are numerous, and 
include metabolic, cardiovascular and immune responses (Dedovic et al., 2009), as well as 
maintaining blood glucose levels (Bergman et al., 2013). Mineralocorticoids control and 
regulate water and electrolyte balance by reduction of sodium ions being excreted from the 
body. This occurs by stimulating reabsorption of sodium ions in the kidneys. Effects of hyper-
secretion causes edema and neuromuscular dysfunction (Bergman et al., 2013). The cortex also 
secretes sex steroids like androgens and estrogens.  
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1.2 The Hypothalamus-Pituitary-Adrenal (HPA) axis  
The first step in the HPA axis (Fig. 1-1) is controlled by a set of hypophysiotrophic 
neurons in the hypothalamic paraventricular nucleus (PVN). PVN synthesize corticotropin 
releasing hormone (CRH) and other factors, such as arginine vasopressin (AVP). CRH and 
AVP are secreted from the hypothalamus and sent via the hypophysial portal veins to the 
anterior pituitary. The anterior pituitary secretes adrenocorticotropic hormone (ACTH) into the 
bloodstream, where ACTH binds to the ACTH receptor (ACTH-R) located on the surface of 
cells present in the adrenal cortex. ACTH-R is also known as the melanocortin 2 receptor (MC2-
R). After stimulation of the ACTH-R, the adrenal cortex secretes glucocorticoids and other 
steroids involved in the stress reaction (Herman et al., 2005). There is also normal secretion of 
glucocorticoids in a non-stressful manner, with a sharp secretion when a person or animal wakes 
up in the morning. The levels of glucocorticoids slowly decline throughout the day (Dedovic et 
al., 2009).  
 
Figure 1-1: The HPA axis. CRH (CRF in the figure) are secreted from the paraventricular 
nucleus in the hypothalamus. CRF binds to the pituitary gland that secrets ACTH. ACTH is 
released into the bloodstream to reach the adrenal cortex, where it binds to the ACTH-R to 
produce glucocorticoids. Glucocorticoids are subsequently sent to various organs in the body. 
To terminate the secretion of ACTH and CRH, glucocorticoids can bind to glucocorticoid 
receptors in the brain in a negative feedback loop. Figure from Hyman (2009).  
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During acute stress, oxygen and nutrients are sent to the central nervous system (CNS) and to 
organs experiencing stress. The organism will increase the respiratory rate in order to deliver 
more oxygen to the organs, while heart rate and blood pressure increase in order to deliver 
sufficient nutrients. Energy mobilization is elevated by gluconeogenesis and lipolysis in the 
liver, which increase levels of glucose to replenish energy stores. Effects on the immune system 
involve suppression of innate immunity in immune organs, controlling the inflammatory 
response. The organism’s ability to grow, reproduce and digest food is also inhibited. All these 
effects continue until glucocorticoids inhibit CRH- or ACTH-secretion until homeostasis is 
restored (Charmandari et al., 2005).  
When an organism is exposed to chronic stress, the HPA axis in the body is activated for a long 
period of time, which results in continuous secretion of CRH and/or steroids. This prolonged 
secretion could cause a number of disorders such as malnutrition, Cushing syndrome and 
hyperthyroidism (Charmandari et al., 2005).  
1.3 The adrenal cortex 
The adrenal cortex consists of three zones known as zona glomerulosa, zona fasciculata 
and zona reticularis (Arnold, 1866). Each zone produces a different class of steroids (Fig. 1-2), 
depending on the enzymes that is present in each zone (Miller et al., 2010).  
Enzymes involved in the steroidogenic pathway are hydroxysteroid dehydrogenases (HSDs) 
and cytochrome P450 (CYPP450) monooxygenase enzymes. The enzymes are found in the 
mitochondria and the endoplasmic reticulum (ER) (Rainey et al., 2004). The cytochrome P450 
enzymes P450scc (CYP11A1), P450c11β (CYP11B1) and P450c11AS (CYP11B2) are located 
within the mitochondria. 3β-hydroxysteroid dehydrogenase (3βHSD) are found in mitochondria 
and ER, whilst P450c17 (CYP17A1) and P450c21 (CYP21) are located within the ER (Miller, 
2013) The P450arom (CYP19) is located in the ER (Miller et al., 2010).  
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Figure 1-2: The steroidogenesis in humans that occur within the three zones in the adrenal 
cortex. The zona glomerulosa produces mineralocorticoids with aldosterone as the main 
endproduct. Glucocorticoids are synthesized in the zona fasciculata with the main product being 
cortisol. The androgens are synthesized in the zona reticularis, where androstenedione and 
testosterone can further be metabolised by CYP19 (aromatase) to give estrone and estradiol 
(not shown). In normal adrenal mouse cells in vivo, the main glucocorticoid endproduct is 
corticosterone (Bloch et al., 1960). Figure from T. S. Han et al. (2014).  
 
ACTH, angiotensin II (Ang II) and potassium (K+) regulate steroidogenesis in the adrenal 
cortex (Figure 1-3). Ang II and K+ mainly regulate the synthesis of mineralocorticoids in zona 
glomerulosa. ACTH is the main hormone that regulates the synthesis of glucocorticoids and 
androgens in the zona fasciculata and reticularis (Rainey et al., 2004).  
1.3.1 Mechanisms of steroidogenesis in response to ACTH  
ACTH binds to ACTH-R on the cell surface (Fig. 1-3). The ACTH-R is a seven 
transmembrane G-protein coupled receptor (Mountjoy et al., 1992). Activation of the receptor 
increases the levels of cAMP (cyclic adenosine monophosphate), which in turn stimulates 
protein kinase A (PKA). PKA can phosphorylate target proteins by releasing an activated 
catalytic subunit. An important target is the cAMP response element binding protein (CREB). 
PKA phosphorylates CREB, which then becomes activated and binds to a specific DNA 
sequence called the cAMP response element (CRE) in the promotor regions of responsive genes 
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(Rehfuss et al., 1991). Genes that are regulated by cAMP are CYP17, CYP11A, CYP11B1, 
CYP11B2 and CYP21 (A. J. Clark et al., 1996).  
However, a difference in CREB expression between adrenal cells in primary culture and the Y1 
mouse adrenocortical cell line has been observed. In the Y1 cell line (chapter 1.4), the CREB 
protein expression is lower compared to primary cultures, while the ATF-1 (activating 
transcription factor 1) protein is overexpressed (Mattos et al., 2005). ATF-1 is another CRE-
binding protein that is regulated by cAMP and PKA, and is expressed in a variety of cell lines. 
The DNA binding site for CREB and ATF-1 are quite similar with a 91 % sequence identity, 
thus ATF-1 probably binds to the same promoter regions as CREB (Rehfuss et al., 1991).  
 
Figure 1-3:  Intracellular cell signalling and mechanisms in adrenocortical cells. The 
agonists Angiotensin II (Ang II), K+ and ACTH bind to membrane receptors and potassium 
channels, leading to steroid synthesis. Figure from (Parmar et al., 2011). 
 
Cholesterol in rodents can be synthesized de novo from acetate in the endoplasmic reticulum, 
but is mainly obtained from high-density lipoproteins (HDL) via the scavenger receptor B1 
(SR-B1) (Temel et al., 1997) and stored in lipid droplets. In humans, cholesterol is obtained 
from low-density lipoproteins (LDL) and stored in endosomes (Miller, 2013). When both 
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human and rodent cells is stimulated with ACTH, free cholesterol is synthesized from the lipid 
droplets by hormone-sensitive lipase (HSL), which is regulated by ACTH.  
 
The rate-limiting step in the steroidogenic pathway is the translocation of cholesterol from the 
outer mitochondrial membrane to the inner mitochondrial membrane via the steroidogenic acute 
regulatory protein (StAR). Subsequently, cholesterol is converted to pregnenolone by side-
chain cleavage of cholesterol via cytochrome P450scc (CYP11A1). A cell is called 
steroidogenic if there is presence of CYP11A1 (Miller, 2013). Pregnenolone is the precursor to 
all steroids produced in adrenocortical cells. Pregnenolone is translocated to the endoplasmic 
reticulum where most of the steroids are synthesised. Corticosterone are synthesized by 
hydroxylation of deoxycorticosterone via CYP11B1 (Bergman et al., 2013).  
1.4 The Y1 adrenocortical cell line 
The term adrenocortical carcinoma means a tumour originating from the epithelial cell 
layer of the adrenal cortex (Fay et al., 2014). The Y1 cell line has its origin from a tumour in 
an adult LAF1 (C57L x A/HeJ) male mouse that was exposed to radiation from a test atomic 
bomb (Cohen et al., 1957b). Slices of the tumour was stimulated with ACTH, and the main 
products were mainly corticosterone and 11β-hydroxy-Δ4-androstene-3,17-dione (Cohen et al., 
1957a). The tumour was incubated in a new Laf1 mice, and the tumour seemed to leave the 
adrenal medulla unchanged, but with a marked atrophy of the adrenal cortex with indication of 
secretion of both glucocorticoids and mineralocorticoids (Cohen et al., 1957b).  
 
Slices of the tumour were grown in culture and mice. Cells grown in culture had a higher ability 
to secrete hormones than the original tumour, but production of steroids declined over time. 
This ability was restored when cultured cells were again administered into animals (Buonassisi 
et al., 1962). From these cultured cells, Yasumura et al. (1966) managed to isolate cells without 
a feeding layer resulting in two distinctive cell types: fibroblastic or epithelial. The epithelial 
cells were cloned, and the subclones were responsive to stimulation by ACTH and produced 
steroid hormones at varying rates. The Y1 clone had the highest secretion of hormones, and this 
secretion was indefinite as long as the serum concentration in the growth medium was high 
(Yasumura et al., 1966).  
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The Y1 cells do not produce steroids when treated with Ang II (Langlois et al., 1990), but  
produce steroids when stimulated with ACTH.  The Y1 cells are one of the few adrenocortical 
cell lines that remains responsive to ACTH, and treatment of the Y1 cells with ACTH increases 
the production of ACTH-R mRNA by up to 6-fold compared to normal levels by activating 
cAMP (Mountjoy et al., 1994). Other analogues that induce cAMP can also start steroidogenesis 
in the Y1 cells. Forskolin is a diterpene (Fig. 1-4) that originates from the Indian plant Coleus 
forskohlii, and is shown to activate adenylyl cyclase and raise levels of cAMP (Schimmer et 
al., 1985). Membranous adenylyl cyclase (mAC) is a membrane bound protein that catalyses 
the conversion of ATP to cAMP.  There are nine isoforms, and forskolin can activate isoform 
AC1-8, but not AC-9. In Y1, forskolin is suggested to activate AC-4 (Rui et al., 2004).  
 
 
Figure 1-4: Chemical structure of forskolin. Figure obtained from MedChem Express.  
 
 
In rodents, as in humans (Fig. 1-3), corticosterone is synthesized in both zona glomerulosa and 
in zona fasciculata by hydroxylation of deoxycorticosterone via either CYP11B2 or CYP11B1, 
respectively. However, the steroid profile of the Y1 cells line is different from the normal 
steroid adrenocortical profile in normal mouse (Fig. 1-5). The main end products produced in 
Y1 are 20α-hydroxy-∆4-pregnen-3-one (20α-dihydroxyprogesterone) and 11β,20α-dihydroxy-
∆4-pregnen-3-one (11β,20α-dihydroxyprogesterone) (Parmar et al., 2011), instead of 
corticosterone and aldosterone. One reason for this deviation is that the levels of the 20α-
hydroxysteroid dehydrogenase (20αHSD) enzyme are increased in Y1 cells (Pierson Jr, 1967). 
 
The other reason for a different steroid profile is deficiency in the CYP21 enzyme in Y1 cells. 
In a study by Parker et al. (1985), Y1 cells were transfected with the 21-OHase gene encoding 
for CYP21. The transfected cells showed increased expression of adrenal 21-OHase mRNA 
and increased volumes of steroids synthesised by CYP21. However, no expression of the gene 
was found in normal untreated cells, suggesting that CYP21 is not present in the Y1 cell line. 
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Still, some corticosterone was detected in untreated cells, but at much lower levels compared 
to cells transfected with the CYP21 gene. The absence of CYP21 expression was later 
confirmed by Amor et al. (1988).  
 
 
Figure 1-5: Steroid biosynthetic pathway in rodents and the special steroid profile in the Y1 
cell line. The pathway in Y1 cells does not involve the CYP21 enzyme, leading to an abnormal 
steroid profile compared to how steroids are synthesized in vivo. Picture adapted from Parmar 
et al. (2011). 
 
 
When stimulated with ACTH, forskolin or cAMP, the cell morphology changes from an 
epithelial cell to a round cell shape, a process called cell rounding (Fig. 1-6). This change is 
mediated through dephosphorylation of paxillin, a focal adhesion protein, causing paxillin to 
translocate from the focal adhesions to the cytoplasm, disorganising stress fibres and the 
rearrangement of the actin cytoskeleton  (J.-D. Han et al., 1996). Actin filaments are involved 
in delivery of cholesterol to mitochondria (Osawa et al., 1984) and might be linked to the change 
of cell morphology.     
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Figure 1-6: Y1 cell morphology. A) Cells after three days of incubation, showing a 
characteristic epithelial shape. B) The cell shape became rounded after stimulation with 0.1 % 
forskolin. Pictures are taken from different flasks. 10x zoom. Y1 cell growth are shown in Fig.4-
1 in results. Pictures by Silje Kathrine Larsen.  
 
1.5 Endocrine disrupting compounds 
The definition for endocrine disrupting compounds (EDCs) can be described as: “An 
endocrine disruptor is an exogenous substance or mixture that alters function(s) of the endocrine 
system and consequently causes adverse health effects in an intact organism, or its progeny, or 
(sub) populations.” Or, “A potential endocrine disruptor is an exogenous substance or mixture 
that possesses properties that might be expressed to lead to endocrine disruption in an intact 
organism, or its progeny, or (sub) populations” (Bergman et al., 2013).  
Persistent organic pollutants, or POPs, is a common description used for chemicals that are 
persistent in the environment, with lipophilic and hydrophobic chemical properties, which often 
leads to POPs being stored and accumulate in fatty tissue. Storage in fatty tissue may lead to 
slow metabolism of the POPs that makes them persistent, and accumulation is often observed 
in food chains. Some POPs can alter hormone response in organs by binding to hormone 
receptors (Jones et al., 1999).  
The adrenal cortex have high lipid content and blood supply, which makes the cortex a target 
for endocrine disruption as many environmental contaminants are taken up into the blood 
stream and distributed to target organs. Here the contaminants can become activated via 
biotransformation in the cells, or stored in lipids. Due to the adrenal cortex being regulated by 
hormones in the HPA axis, the cortex may be a target for hormone disruption by endocrine 
disrupting compounds binding to hormone receptors (Bergman et al., 2013).    
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1.5.1 Perfluorinated compounds (PFCs) 
Perfluorinated compounds (PFCs) are synthetic compounds which structure consists of 
carbon chains bound to fluoride atoms. This is a strong bond making the chemicals highly 
resistant to biological degradation, and therefore these compounds can accumulate in the 
environment. PFCs have been detected in water and water living creatures, plants, foodstuffs 
and in blood and breast milk in humans. PFCs are in general used as a water and oil repellent 
or coating in textiles, furniture, food packaging and cooking utensils (Stahl et al., 2011).  
The PFCs present in the mixture used in this thesis, include six compounds: perfluorooctanoic 
acid (PFOA), perfluorooctane sulfonate potassium salt (PFOS), perfluorodecanoic acid 
(PFDA), perfluorononanoic acid (PFNA), perfluorohexanesulfonic acid potassium salt 
(PFHxS), perfluorododecanoic acid (PFUnDA). Of these six, PFOS and PFOA (Fig. 1-7) are 
the most studied PFCs and considered the most harmful (Fromme et al., 2009).  
 
Figure 1-7: Chemical structure of PFCs represented by PFOS. Figure from Wikimedia 
(2015).  
1.5.2 Polybrominated compounds (PBCs) 
Polybrominated diphenyl ethers (PBDEs) are one of the most commonly used flame-
retardants, and are found in many everyday items consisting of plastics, rubber, textiles and 
furnishing foam to improve fire resistance. PBDEs are aromatic bromine compounds that are 
favourable as flame-retardants because of their thermostability, and have weak carbon-bromide 
bonds that breaks at a certain temperature. The flame-retardant often decomposes at 
temperatures lower than the material in which it is added, as this prevents the formation of 
flammable gases. There are 209 possible congeners for PBDEs, and consist of an aromatic 
chemical structure which properties are similar to PCBs, DDT and polybrominated biphenyls 
(PBB) (Rahman et al., 2001).  
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Figure 1-8: General chemical structure of PBDEs. The most active substitution sites of 
binding of Br is marked (*). Figure from Rahman et al. (2001).  
 
The use of flame retardants is growing, but information of which flame retardants are produced 
and how they are spread into the environment is lacking, as well as their toxicity. PBDEs are 
extremely persistent in the environment, as they are resistant to degradation by acids, bases, 
heat and light (Rahman et al., 2001). PBDEs are also highly lipophilic, and combined with their 
stability are likely to bioaccumulate and are found more persistent than PCBs in the 
environment (de Boer et al., 1998). BDE-209 are found in sediments and sewage as the main 
PBDE and are also found in human blood serum (Alaee et al., 2003).  
The PBCs in the mixture include five compounds: 2,2′,3,3′,4,4′,5,5′,6,6′-deca bromodiphenyl 
ether (BDE-209), 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47), 2,2′,4,4′,5-
pentabromodiphenyl ether (BDE-99) and 2,2′,4,4′,5,6′-hexa bromodiphenyl ether (BDE-154) 
and hexabromocyclododecane (HBCD).  
 
Hexabromocyclododecane (HBCD) consists of three isomers (α, β and γ) formed from 
bromination of cyclododecatriene (Fig. 1-9), and is mainly used in polystyrene foam in building 
constructions. HBCD might be less persistent than PBDEs in nature as HBCD is less thermo 
stabile (Alaee et al., 2003).  
 
Figure 1-9: Chemical structure of HBCD. The HBCD α, β and γ isomers are shown from 
left to right. Figure from Alaee et al. (2003).  
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1.5.3 Chlorinated compounds 
The polychlorinated biphenyls (PCBs) are amongst the most known and studied POPs 
present in the environment (Jones et al., 1999). PCBs are of an environmental and health 
concern because of the persistence and bioaccumulation and their carcinogenic abilities. One 
of the uses of PCBs have been as insulating fluids used for industrial purposes (Otchere, 2005). 
There are 209 possible congeners for PCBs, and consist of an aromatic chemical structure 
(Fig.1-10) (Rahman et al., 2001). PCB 153 is the most abundant congener in biological samples.  
The PCBs in the mixture include seven compounds: PCB 138, PCB 153, PCB 101, PCB 180, 
PCB 52, PCB 28 and PCB 118.  
 
Figure 1-10: General chemical structure of PCB. referer 
1.5.4 Pesticides 
The pesticides in the mixture are organochlorides represented by p,p’-dichlorodiphenyl 
dichloroethene (p,p’-DDE), hexachlorobenzene (HCB), chlordanes (α-chlordane, oxy-
chordane, trans-nonachlor), hexachlorocyclohexane (α-HCH, β-HCH, γ-HCH) and dieldrin. 
Like with PCBs, many of these pesticides were banned from use in from the 1970s and 1980s. 
But still many pesticides are found in soil (Martinez et al., 2012).  
The chemical DDT is an organochlorine pesticide which also is an historically important 
persistent organic pollutant (Jones et al., 1999). The organochloride represented in the mixture 
is p,p’-dichlorodiphenyl dichloroethene (p,p’-DDE) a compound that is made during the 
metabolic breakdown of DDT in e.g. humans. Amongst the well-described effects of DDE-
exposure is reduction in thickness in eggshells in birds (Jones et al., 1999). DDE is the most 
stable DDT metabolite, so even though use of DDT were banned in many developing countries, 
DDE is still being detected in human blood (Korrick et al., 2000).  
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Figure 1- 11: Chemical structure of p,p’-DDE. Figure from Pesticideinfo (2015)  
 
Another pesticide is hexachlorobenzene (HCB) a chlorinated compound formed as a byproduct 
during manufacturing of chlorinated solvents, chlorinated compounds, or pesticides (Korrick et 
al., 2000). HCB was introduced as a fungicide, but are not banned from use in many countries 
(Barber et al., 2005).  
1.6 Aim of the study  
This master project is part of a larger national and international project on effects of 
persistent organic pollutants on stress production managed by Professor Erik Ropstad at the 
Norwegian School of Veterinary Science (NVH). The POPstress project overall aim is to 
investigate the effects on POPs on the function and development of the HPA axis in vivo and 
in vitro. The environmental toxicology group in University of Bergen studies the effects in the 
human H295R and mouse Y1 adrenocortical cell lines.    
The aim of this study was to investigate how a mixture of persistent organic pollutants (POPs) 
would affect the steroid production in Y1 mouse adrenocortical cells. This was studied under 
two conditions: 1) if a mixture of POPs could induce steroid production in normal cells under 
no stress influence and 2) if a mixture of POPs had an antagonistic, synergistic or additive effect 
steroid production of stress hormones in cells already being stress-induced by forskolin.  
To obtain this goal, a metabolomics approach was utilized. A newly established method for 
studying steroids in the steroidogenic pathway at the Hormone Laboratory of the Haukeland 
University Hospital using LC-MS/MS was used for this purpose. Effects on enzymes by 
immunological detection using antibodies was also studied.   
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2. MATERIALS 
2.1 Total concentrations of POPs in the original mixture and exposure dilutions 
Chemical 1X* 1:103† 1:104† 1:106† 1:106† 
 mM mM mM mM mM 
PFOA 10.922 0.010922 1.0922E-06 1.0922E-11 1.0922E-17 
PFOS POTASSIUM SALT 54.671 0.054671 5.4671E-06 5.4671E-11 5.4671E-17 
PFDA 0.963 0.000963 9.63E-08 9.63E-13 9.63E-19 
PFNA 1.724 0.001724 1.724E-07 1.724E-12 1.724E-18 
PFHxS POTASSIUM SALT 7.855 0.007855 7.855E-07 7.855E-12 7.855E-18 
PFUnDA 0.993 0.000993 9.93E-08 9.93E-13 9.93E-19 
BDE-209 0.011 0.000011 1.1E-09 1.1E-14 1.1E-20 
BDE-47 0.018 0.000018 1.8E-09 1.8E-14 1.8E-20 
BDE-99 0.006 0.000006 6E-10 6E-15 6E-21 
BDE-154 0.003 0.000003 3E-10 3E-15 3E-21 
HBCD 0.038 0.000038 3.8E-09 3.8E-14 3.8E-20 
PCB 138 0.615 0.000615 6.15E-08 6.15E-13 6.15E-19 
PCB 153 1.003 0.001003 1.003E-07 1.003E-12 1.003E-18 
PCB 101 0.024 0.000024 2.4E-09 2.4E-14 2.4E-20 
PCB 180 0.491 0.000491 4.91E-08 4.91E-13 4.91E-19 
PCB 52 (representative consumers) 0.033 0.000033 3.3E-09 3.3E-14 3.3E-20 
PCB 28 (representative consumers) 0.05 0.00005 5E-09 5E-14 5E-20 
PCB 118 0.196 0.000196 1.96E-08 1.96E-13 1.96E-19 
p,p`-DDE 1.578 0.001578 1.578E-07 1.578E-12 1.578E-18 
HCB 0.411 0.000411 4.11E-08 4.11E-13 4.11E-19 
α-chlordane 0.026 0.000026 2.6E-09 2.6E-14 2.6E-20 
oxy-chordane 0.052 0.000052 5.2E-09 5.2E-14 5.2E-20 
trans-nonachlor 0.092 0.000092 9.2E-09 9.2E-14 9.2E-20 
α-HCH 0.021 0.000021 2.1E-09 2.1E-14 2.1E-20 
β-HCH 0.181 0.000181 1.81E-08 1.81E-13 1.81E-19 
γ-HCH (Lindane) 0.021 0.000021 2.1E-09 2.1E-14 2.1E-20 
Dieldrin 0.063 0.000063 6.3E-09 6.3E-14 6.3E-20 
* Original mixture, all compounds dissolved in DMSO 
† Original mixture diluted in Y1 growth media to make four doses of the mixture 
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2.2 General chemicals 
Chemical name Company  Catalogue No./ Lot No 
Albumin, from bovine serum (BSA) Sigma-Aldrich A9647/051M1873V 
Aluminum sulfate hydrate  Sigma-Aldrich 368458/MKBF0413V 
Ammonium hydroxide solution (25 %) Sigma-Aldrich 44273 
Ammonium persulfate (APS) Sigma-Aldrich A9164/MKBF0028V 
Bromophenol blue Merck 108122 
CHAPS hydrate Sigma-Aldrich C9426 
Coomassie® Brilliant Blue G 250 (CBB G 250) Merck 115444 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich D8418 
Dithiothreitol (DTT) AppliChem A2948 
Ethanol (EtOH) Sigma-Aldrich 32221 
Ethylenediaminetetraacetic acid (EDTA) Merck 324503 
Forskolin, from Coleus forskohlii VWR 
International 
344270 
Glycerol Sigma-Aldrich G5516/ STBC1888V 
Glycine Sigma-Aldrich G8898/SZBD157CV 
Hydrochloric acid (HCl) 37 % Merck 100317 
Iodoacetamide Sigma-Aldrich I6125/030M5315V 
KCl Sigma-Aldrich P9541/080M0091V 
Methanol (MeOH) Sigma-Aldrich 34860N 
N,N,N’,N’-tetramethyl-ethylenediamine 
(TEMED) 
Sigma-Aldrich T9281 
Ortho-phosphoric acid Merck 100573  
Pharmalyte 3-10 for IEF GE Healthcare 17-0456-01/10040852 
Phenylmethylsulfonyl Fluoride (PMSF) in 
DMSO 
Santa Cruz 
Biotechnology 
sc-24948 
Potassium dihydrogen phosphate Merck 104873  
SeaKem LE Agarose Lonza 50004 
Sodium chloride Merck 106404 
Sodium dodecyl sulfate (SDS) (20 % w/v) Amresco M112 
Sodium Orthovanadate Santa Cruz 
Biotechnology 
sc-24948 
Sodium phosphate dibasic dihydrate Sigma-Aldrich 30435/SZBE0760V 
Sucrose Sigma-Aldrich 84100/SZBC0120V 
Thiourea Merck 107979  
Trizma® base  Sigma-Aldrich T1503/SLBC9023V 
Urea Merck 108487 
β-mercaptoethanol Sigma-Aldrich M6250 
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2.3 General solutions, compounds, media and supplements 
Chemical name Company  Catalogue No./ Lot 
No 
30 % Acrylamide: Bis-acrylamide solution, 
37.5:1  
Sigma-Aldrich A3699  
Cleaning concentrate  BIO-RAD 161-0722 
Fetal Bovine Serum Sigma-Aldrich F6765/11H316 
Ham's F-12K (Kaighn's) Medium Gibco by Life 
Technologies 
21127-022/1568502 
Non-fat dried milk Normilk AS  
NuSerum™ Culture Supplement BD Biosciences 355100 
Penicillin-Streptomycin (Pen-Strep) Gibco by Life 
Technologies 
15140-122/1469711 
Pierce 660 nm Protein Assay Reagent Thermo 
Scientific 
22660 
PlusOne DryStrip cover Fluid GE Healthcare  17-1335-01 
Protein inhibitor cocktail in DMSO Santa Cruz 
Biotechnology 
sc-24948 
Restore PLUS Western Blot Stripping Buffer Thermo 
Scientific 
46430 
RIPA Lysis Buffer System Santa Cruz 
Biotechnology 
sc-24948 
Trypan Blue Stain Cambrex Bio 
Science 
17-942E 
Trypsin-EDTA solution 0.25 % Sigma-Aldrich T4049/SLBG2806 
Tween-20 Sigma-Aldrich P5927 
 
2.4 Kits 
Name Description Company/ 
Catalogue No./ Lot No 
SuperSignal® West Femto 
Maximum Sensitivity Substrate  
Western blot 
chemiluminescence kit 
Thermo Scientific 
/34095/PJ207501A 
SuperSignal®  West Pico 
Chemiluminescent Substrate 
Western blot 
chemiluminescence kit 
Thermo Scientific 
/34080/OG190590 
 
2.5 Eukaryotic cell lines 
Name Description Supplier 
H295R Human adrenocortical cell line Hormone Laboratory 
Haukeland University Hospital 
HepG2 Human liver hepatocellular carcinoma cell line Roger Lille-Langøy 
Y1 Mouse adrenocortical cell line Hormone Laboratory 
Haukeland University Hospital 
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2.6 Molecular weight and size standard 
Name Description Company/Catalogue No. 
Precision Plus Protein™ All 
Blue Prestained 
Ten blue-stained recombinant 
proteins (10-250 kDa) 
BIO-RAD/161-0373 
 
2.7 Antibodies 
Antibody Produced 
in 
Isotype 
/CyDye 
Reactivity  Company Product 
number 
 
Anti-beta Actin  Mouse IgG3 Monoclonal Abcam ab8224 
Anti-CYP11A1 Rabbit IgG Polyclonal Abcam ab175408 
Anti-CYP11B2  Rabbit IgG Monoclonal Abcam ab167413 
Anti-CYP19 (H-300) Rabbit IgG Polyclonal Santa Cruz 
Biotechnology 
sc-30086 
Anti-StAR (K-20) Goat IgG Polyclonal Santa Cruz 
Biotechnology 
sc-23524 
Anti-Goat IgG,  
Cy5 conjugate 
Donkey IgG/Cy5 Polyclonal Abcam ab6566 
Anti-Rabbit IgG, 
HRP conjugate 
Goat IgG Polyclonal Dako Denmark 
A/S 
P0448 
ECL Plex™ anti-
mouse IgG, Cy3 
conjugate 
Goat IgG/Cy3 Mono 
reactive 
GE Healthcare PA43009
V 
ECL™ anti-mouse 
IgG, HRP linked 
whole antibody 
Sheep IgG  GE Healthcare NA931V 
ECL Plex™ anti-
rabbit IgG, Cy5 
conjugate 
Goat IgG/Cy5 Mono 
reactive 
GE Healthcare PA45011
V 
 
2.8 Consumables 
Name Company Catalogue No.  
Amersham Hybond LFP (pore size 0.2 µm) PVDF GE Healthcare 10600060 
Immobilon-p Transfer membrane (pore size 0.45 µm) 
PVDF 
Millipore IPVH00010 
Immobiline Drystrip (IPG) pH 4-7, 7 cm GE Healthcare 17600110 
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2.9 Instrumentation 
Category Name Manufacturer 
Blotting Mini PROTEAN®  Tetra Cell BIO-RAD 
Cell counting  Bürker hemocytometer Kebo Lab 
Centrifugation CT 15RE Himac VWR 
 Galaxy MiniStar VWR  
 Heraeus Multifuge X3R  Thermo Scientific 
Electrophoresis Mini PROTEAN®  3 Cell BIO-RAD 
 Mini PROTEAN®  3 Dodeca™ Cell BIO-RAD 
Heating Thermomixer compact Eppendorf  
Isoelectric focusing Ettan IPGphor 3 IEF System GE Healthcare 
Imaging ChemiDoc™ XRS+ Imaging System BIO-RAD 
 GS-800 Calibrated Densitometer BIO-RAD 
 Typhoon FLA 9000 GE Healthcare 
Incubation  Galaxy 170 R New Brunswick 
LLE Star pipetting robot Hamilton® 
Microscopy Leica DMIL LED Leica Microsystems 
Mixing  VWR International 
 Vortemp 56 EVC Labnet 
 Vortex-Genie 2™ Scientific Industries  
pH measurement pHM210 Standard pH Meter MeterLab® 
Plate reading EnSpire™ 2300 Multilabel Reader PerkinElmer 
Power supply PowerPac™ HC BIO-RAD 
Shaker IKA® HS 260 basic IKA-Werke 
Sonication Transsonic 460 Elma 
 Ultrasonic Homogenizer 4710 Series  Cole-Parmer Instrument Co. 
Steroid profiling Xevo T-QS triple quadrupole mass 
spectrometer 
Waters 
 Acquity UPLC i-class Waters 
Water supply Advantage A10 Millipore 
Weighing EK-300i AND 
 SI-64 Denver Instrument 
 
2.10 Water quality 
MΩcm@250C: 18.2 
Ppb TOC: 5 
 
Deionised type 1 ultrapure water, Milli-Q  
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2.11 Media, buffers and solutions 
Y1 cell growth  
Y1 growth media 
1 x Ham's F-12K (Kaighn's) Medium 
10 % FBS (v/v) 
1 % Pen-Strep (v/v) 
 
Forskolin for stimulation 
Forskolin (in DMSO) 
10 mM Forskolin 
 
Mitochondria isolation 
 
 
 
 
 
Sucrose lysis buffer - stock solution 
250 mM Sucrose  
10 mM Tris-HCl pH = 7.4  
0.1 mM EDTA  
       
Protein measurement 
Standard (Pierce 660 assay) 
BSA (10mg/mL) 30 mg 
Sucrose lysis buffer 3 mL 
 
Whole protein lysate 
 
 
 
 
 
1xPBS 
NaCl 4 g 
KCl 0.1 g 
Na2HPO4 0.72 g 
KH2PO4 0.12 g 
Adjust pH to 7.4 with 6 M HCl 
dH2O  up to 500 mL 
Sucrose lysis buffer w/inhibitors 
1 mM PMSF 1 µL  
1 mM protein inhibitor cocktail 1 µL  
1 mM  sodium orthovanadate 1 µL  
Sucrose lysis buffer  200 µL 
 Add inhibitors just before use  
RIPA 
1 mM PMSF 10 µL  
1 mM protein inhibitor cocktail 10 µL  
1 mM  sodium orthovanadate 10 µL  
RIPA buffer lysate system 1 mL 
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General electrophoresis 
 
10 x TGS Running buffer  
250 mM Tris 
1920 mM glycine 
1 % SDS (v/v) 
 
 
 
 
 
 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis  
 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
Colloidal coomassie 
Aluminumsulfate 100 g 
dH2O 800 mL 
Ethanol 200 mL 
CBB G-250 0.4 g 
Phosphoric acid 47 mL 
dH2O up to 2 L 
Destaining 
dH2O 800 mL 
Ethanol 200 mL 
Phosphoric acid 47 mL 
dH2O  up to 2 L 
10 % running gel (10 mL) (all amounts v/v) 4 % stacking gel (5 mL) (all amounts v/v) 
dH2O 4 mL dH2O 3.1 mL 
1.5 M Tris-HCl pH 8.8 2.5 mL 0.5 M Tris-HCl pH 6.8 2 x 625 µL 
10 % SDS 100 µL 10 % SDS 50 µL 
Acrylamide 3.33 mL Acrylamide 650 µL 
10 % APS 50 µL 10 % APS 25 µL 
TEMED 5 µL TEMED 5 µL 
12.5 % running gel (10 mL) (all amounts v/v) 4 % stacking gel (5 mL) (all amounts v/v) 
dH2O 3.3 mL dH2O 3.1 mL 
1.5 M Tris-HCl pH 8.8  1.3 mL 0.5 M Tris-HCl pH 6.8 2 x 625 µL 
10 % SDS 0.05 mL 10 % SDS 50 µL 
Acrylamid 2.0 mL Acrylamid 650 µL 
10 % APS 0.05 mL 10 % APS 25 µL 
TEMED 0.002 mL TEMED 5 µL 
5 x Sample buffer (5xSB) 
250 mM Tris-HCl pH = 6.8 
10 % SDS ( 
30 % glycerol 
5 % β-mercaptoethanol 
0.02 g bromophenolblue  
1 x Sample buffer (1xSB) 
5xSB 20 % (v/v) 
dH2O 80 % (v/v) 
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Western blot 
 
 
 
 
Tris buffered saline (TBS) buffers 
 
 
 
 
 
 
 
 
 
 
LC-MS/MS 
 
ethylacetate:hexane (80:20 % vol/vol) 
 
 
 
 
 
 
2D electrophoresis  
 
Whole cell lysate 
 
  
 
 
 
 
 
10 x Transfer buffer 
Tris 30.3 g 
Glycine 144 g  
dH2O up to 1000 mL 
1 x Transfer buffer 
10 x Transfer buffer 100 mL 
Methanol 200 mL 
dH2O up to 1000 mL 
5 x TBS 
Tris 24 g 
NaCl 292.5 g  
dH2O  up to 1800 mL 
Adjust pH to 7.5 with 6 M HCl 
dH2O  up to 2000 mL 
0.05 % TBS-Tween (TBST) 
5x TBS 200 mL 
Tween-20 0.5 mL 
dH2O 800 mL 
Blocking solution 
5 % non-fat dry milk (w/v) 
1 x TBST 
Stripping buffer  
100 mM β-mercaptoethanol  
2 % SDS  
62.5 mM Tris-HCl pH 6.8  
Mobile phase B 
Methanol 
0.05 % ammonium hydroxide solution (v/v) 
Mobile phase A 
dH2O 
0.05 % ammonium hydroxide solution (v/v) 
Homogenization buffer (2D HB) 
7 M Urea 4.2042 g 
4 % Chaps (w/v) 0.4 g 
2 M Thiaurea 1.5224 g  
30 mM TrisHCl (pH = 8.5) (v/v) 600 µL 
dH2O  up to 10 mL 
Standard (Pierce 660 assay) 
BSA (10mg/mL) 30 mg 
2D Homogenization buffer 3 mL 
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2D separation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 x Rehydration buffer (fresh batch) 
8 M Urea 4.804 g 
4 % Chaps (w/v) 0.4 g 
Pharmalyte 100 µL 
13 mM DTT 0.02 g 
dH2O up to 10 mL 
20 % Equilibration buffer - stock solution  
50 mM 1.5 M TrisHCl pH 8.8 6.7 mL 
6 M Urea 72.07 g 
30 % Glycerol (v/v)  
2 % SDS (w/v) 4 g 
Bromophenol blue Few grains 
dH2O  up to 200 mL 
Equilibration buffer A w/DTT 
Dithiothreitol  0.1 g 
20 mL eq.buffer   
Equilibration buffer B w/IAA 
Iodoacetamide  0.9 g 
20 mL eq.buffer   
12.5 % (6 gels) (all amounts v/v) 
dH2O 20.1 mL 
1.5 M Tris-HCl pH 8.8 15 mL 
10 % SDS 600 µL 
Acrylamid 24 mL 
10 % APS 300 µL 
TEMED 30 µL 
Agarose for sealing IPG strip 
1 % agarose   
1XTGS buffer 
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3. METHODS 
3.1 Experimental overview 
 
 
Figure 3-1: Overview of the main steps from exposures to sample analysis.  
 
3.2 Cultivation of Y1 cells  
Y1 cells were grown in HAM’s F-12K (Kaighn’s) medium supplemented with 10 % 
charcoal stripped fetal bovine serum (FBS) and 1 % Penicillin-Streptomycin (Pen-Strep). Cells 
were incubated in a heating cabinet adjusted to 37℃ and with 5 % CO2 in a humified 
atmosphere. Media was changed every two days until reaching 70 - 80 % cell confluence. Cells 
were initially cultured in 75 cm2 tissue culture media flasks before seeded into 6-well plates for 
the exposure and timeline experiments. Cell culture techniques previously described by Hecker 
et al. (2007) for the H295R cell line were used as a guideline.  
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3.2.1 Cultivation of parental Y1 cells  
Y1 cells were obtained from Haukeland University Hospital, and this vial was used to 
make parental cells. Cells in the vial were thawed and then seeded in a 75 cm2 tissue culture 
media flask and incubated overnight. The cells had been stored in freeze media that contained 
DMSO, so media was changed the next day when the cells had attached to the flask bottom. 
This would ensure that DMSO was removed from the growth media and not affect the cells. 
Media was changed every two days until reaching 70 - 80 % cell confluence. The cells were 
added 0.25 % trypsin-EDTA to detach cells from the flask and suspended in freeze media 
containing 5 % DMSO. The suspension of cells were divided into aliquots of approximately 
0.5 mL and stored in – 800C for 24 hours before transferred to liquid nitrogen. All these vials 
contains parent cells, deriving from that one vial from Haukeland.  
3.2.2 Cultivation of cells for experiments 
One parental cell vial was thawed and cultured for three passages. For the first passage, 
cells were subcultured 1:5 in four new flasks. During the second passage, cells from two flasks 
was stored in aliquots of approximately 0.5 mL in liquid nitrogen. The other two flasks were 
used for further expansion by dividing the cells 1:5 into eight new flasks. For the third passage, 
all cells were harvested and stored in aliquots in liquid nitrogen. The number of cell vials from 
this one expansion was more than 40 vials. As one frozen vial was used for one experiment 
(pilot samples, timeline, exposure), this was enough cells for more than 40 experiments. All 
vials were stored in liquid nitrogen until used.   
3.2.3 Subculturing  
Cells were subcultured, or passaged, when the cell confluence was at 70 - 80 % per 
flask. Passaging was done by removing old media and washing cells with 1.5 mL 0.25 % 
trypsin-EDTA. 2 mL trypsin-EDTA was added to the cell flask and incubated for 5-7 minutes 
in 370C until the cells had detached. 8 mL media was subsequently added to stop the 
trypsinization process. The cell suspension was collected in a 15 mL falcon tube and centrifuged 
at 1250 rpm for three minutes (Heraeus Multifuge X3R). The supernatant was removed and the 
cell pellet was dissolved in 10 mL Y1 growth media. Usually, the cells was divided 1:5 by 
adding 2 mL of the cell pellet suspension in a new flask containing 8 mL Y1 growth media.   
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To ensure that the cells were stable and fully adopted to the growing conditions, cells were 
subcultured four times into 75 cm2 flasks. The fourth subculture was called passage 4. Then, on 
the fifth subculturing, or passage 5, the cells were seeded onto 6-well plates.  
3.2.4 Cell counting and seeding onto 6-well plates  
After trypsinization and centrifuging the cells (chapter 3.2.3), each cell pellet was 
resuspended in 5 mL Y1 growth media and transferred to a 50 mL Falcon tube. 100 µL of the 
cell suspension was mixed with 100 µL tryptophan blue. Then the cell concentration was 
calculated using a Bürker hemocytometer. The cell number was determined by calculating the 
mean cell number from five squares on the hemocytometer.    
To calculate the number of cells/mL: 
n (mean cell number) x 2 x 10000 = X cells/mL.  
Cells were diluted with Y1 growth media to a concentration of 1.2 x 106 cells/mL. Thereafter, 
cells were seeded by adding 1 mL to each well and incubated overnight.  
3.2.5 Harvesting cell samples (6-well plates) 
Both media and cells were collected for analysis. Media from each well were transferred 
directly to Eppendorf tubes. Cells were harvested by the trypsinization method. Any leftover 
media was removed by washing each well with 250 µL 0.25 % trypsin-EDTA. Each well were 
then added 350 µL trypsin-solution directly on the washed cells and incubated for 5 minutes. 
Cells were harvested by adding 800 µL Y1 growth media, and transferred to Eppendorf tubes. 
Suspended cells were centrifuged at 13000 x g for 5 minutes at 40C, and the supernatant was 
removed from the cell pellet. Media was stored in – 200C and cells in – 800C until further 
analysis.     
3.3 Timeline for measuring basal steroidogenesis in stimulated cells 
Cells were stimulated with forskolin in order to measure changes in the steroidogenesis 
pathway over time. This would give an overview of the basal steroid production in Y1 cells. 
Cells were forskolin-stimulated for a given time period between 0 and 48 hours, and cells and 
media from each well were collected for steroid analysis.  
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Table 1: Overview of cells and media sampling  
 
 Time points (h) 
Timeline 0 0.5 1 2 4 8 12 24 48 
 
Y1 cells were prepared and plated out in 6-well plates (chapter 3.2.4). The next day, old media 
was discarded and 1 mL Y1 growth media containing 0.1 % forskolin was added to each well. 
Each time point were performed in duplicates (Fig. 3-2). Cells and media from the two wells 
representing time 0 were collected immediately after adding media as previously described 
(chapter 3.2.5). Samples were collected for the remaining wells throughout the timeline. Media 
was stored in – 200C and cells in – 800C until further analysis.  
 
 
Figure 3-2: The 6-well plate setup for 48-hour time line. Three 6-well plates were used, with 
two wells dedicated for each time point.  
 
One timeline was performed with longer incubation up to 72 hours. Results from this timeline 
is listed in Appendix D. 
3.4 Cytotoxicity testing 
AlamarBlue® assay (Invitrogen) was used as a cell viability test after exposures. This 
was performed to control if the exposure regimes are cytotoxic to the Y1 cells. This assay 
measures the proliferation of cells, and does so by detecting metabolic activity. Healthy and 
active cells convert the alamarBlue® reagent into a fluorescent and colorimetric indicator. If 
the cells are dead or damaged, there will be less reagent converted.   
Y1 cells were grown and plated at out at passage 5 in a black 96-well fluorescent plate, in a cell 
density of 10000 cells/well. Every condition were measured five times, so 45 wells were plated 
with Y1 cells. The plate was incubated for 24 hours at 37℃. The next day the exposures was 
prepared by making nine different controls and mixtures (Table 2). For a positive control, cells 
were treated with 0.1 % Triton X-100, a detergent that disrupt the cytoplasm membranes and 
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cause cell death (Borner et al., 1994). Negative control was normal media (non-treated). Old 
media was removed and discarded, and controls and exposures were distributed on the plate at 
100 µL per well. The plate was incubated for 48 hours.  
 
Table 2: Cytotoxicity setup.  
Control DMSO Forskolin Mixture 10-3 
Unstimulated 
Mixture 10-3 
Stimulated 
Mixture 10-4 
Stimulated 
Mixture 10-5 
Stimulated 
Mixture 10-6 
Stimulated 
0,1 % 
Triton-X 
 
After the 48 hours exposure, 100 µL of media was added to five wells as a non-cell positive 
control. Since this was a control without cells, this required no previous incubation before 
adding alamarBlue®. Afterwards, 10 µL of alamarBlue® was added to each well and the plate 
was further incubated for 22.5 hours. Fluorescence was measured at 540 nm excitation and 590 
nm emission using an Enspire™ Multilabel Reader.   
3.5 Exposures to mixture of POPs 
To find out how the mixture (Materials 2.1) would influence the steroidogenic pathway, 
Y1 cells were exposed to four doses of the mixture (Materials 2.1) for 48 hours under two 
different conditions. The first condition was unstimulated cells, meaning that the cells were not 
treated with forskolin. With this approach, if an increase in steroid production were observed, 
it would indicate that one of the compounds in the mixture could activate steroid production. 
The second condition was exposure of stimulated cells, meaning that cells were treated with 
forskolin as well as the mixture. By activating the steroid production in the cell using forskolin, 
it could be measured if the mixture had an additive or inhibitory effect on steroid production in 
the cells. The mixture were distributed in four doses by serial dilution in Y1 growth media as 
illustrated in Figure 3-3 and 3-5.  
3.5.1 Exposures on unstimulated cells 
Cells were seeded in three 6-well plates (chapter 3.2.4) and incubated overnight. The 
next day, the mixture was diluted in Y1 growth media (Materials 2.10) resulting in four different 
doses of the mixture (Fig. 3-3). Control media was made separately by adding 0.1 % DMSO to 
Y1 growth media. Old media was removed from each well in the three 6-well plates, and the 
control media and the mixtures were distributed between the wells (Fig. 3-4). Plates were then 
incubated in 370C and cells and media harvested after 48 hours (chapter 3.2.5).  
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Figure 3-3: Illustration of making the four doses of the mixture in HAM’s F-12K 
(Kaighn’s) medium by serial dilution for unstimulated cells. Highest to lowest dose is 
1:1000 (1:103), 1:10000 (1:104), 1:100000 (1:105) and 1:1000000 (1:106).  
 
 
 
Figure 3-4: Example of one 6-well plate setup for unstimulated cells. For each exposure, 
the setup was rearranged to minimize the impact of cell well placement. One exposure included 
three 6-well plates, so that each dilution had three replicates.   
3.5.2 Exposures on forskolin-stimulated cells  
Cells were seeded in three 6-well plates (chapter 3.2.4) and incubated overnight. The 
next day, the mixture was diluted in Y1 growth media containing 0.1 % forskolin, resulting in 
four doses of the mixture (Fig. 3-5). Control media was made separately by adding 0.1 % 
forskolin to Y1 growth media. Old media was removed from each well in the three 6-well plates, 
and the control media and the mixtures were distributed between the wells (Fig. 3-6). Plates 
were then incubated in 370C and cells and media harvested after 48 hours (chapter 3.2.5).  
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Figure 3-5: Illustration of making the four doses of the mixture in HAM’s F-12K 
(Kaighn’s) medium by serial dilution for stimulated cells. The media was added 0.1 % 
forskolin before mixture was diluted. Highest to lowest dose is 1:1000 (1:103), 1:10000 (1:104), 
1:100000 (1:105) and 1:1000000 (1:106). 
 
 
Figure 3-6: Example of a 6-well plate setup for stimulated cells. For each exposure, the setup 
were rearranged to minimize the impact of cell well placement. One exposure included three 6-
well plates, so that each dilution had three replicates.   
 
3.6 Steroid profiling of metabolites by liquid chromatography - 
tandem mass spectrometry (LC-MS/MS) 
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is able to detect and 
determine multiple steroids at very low concentrations with high specificity in a single 
analytical run (Methlie et al., 2013). This method combines chromatography and mass 
spectrometry, by separating molecules and identify them according their mass and charge.  
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Samples are first injected into an ultra performance liquid chromatographer (UPLC). The 
analytes in that sample are moved through a column (the stationary phase) by the flow of a 
solvent, referred to as the mobile phase, under high pressure. Different analytes vary in their 
affinity and solubility to the stationary- and mobile phases, respectively, thereby they become 
separated as they pass through the column (Fig. 3-7). As soon as compounds elute, compounds 
are sent to the mass spectrometer for detection (Fig. 3-8). 
 
 
Figure 3-7: How the individual compounds in an analyte sample are separated as sample 
moves through the column. Mobile phase is the solvent the sample are diluted in, and the 
column is the stationary phase. Picture from Waters.  
 
 
 
 
Figure 3-8: Overview of liquid chromatography, representation by high performance LC 
(HPLC). The principle is the same for HPLC and UPLC. The difference between the two is 
that the chromatogram is more sensitive and precise using UPLC. Picture from Waters.  
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The mass spectrometer used in this study was a triple quadrupole mass spectrometer type fitted 
with an electrospray ionisation (ESI) ion source. ESI is the transition stage from the UPLC to 
the mass spectrometer (Fig. 3-9).  
After running the sample through the column, the liquid sample is pumped through a metal 
capillary that has a positive or a negative voltage, resulting in a positive or negative charge of 
the sample. At the capillary tip the charged liquid is nebulised (conversion of liquid to aerosol 
droplets) which gives a fine spray of charged droplets. The droplets passes down a pressure 
gradient, where the droplets are reduced in size by evaporation with hot nitrogen gas. This size 
reduction decrease droplet radius and increases the surface charge density, and the droplets 
enters the gaseous phase. The gas phase ions enters the mass spectrometer (Ho et al., 2003). 
Analysis of ions produced during the ionization process is based on mass to charge ratio (m/z) 
(Pitt, 2009).  
 
 
Figure 3-9: Electrospray ionisation. Picture from LamondLab.  
 
After entering the triple quadrupole mass spectrometer, the gas phase ions travels through three 
sets of rods (Q1, Q2 and Q3), that each consist of four parallel metal rods, or quadrupoles (Fig. 
3-10). The first metal rod, Q1, functions as a mass filter that recognize an ion of interest based 
in mass. The Qi sends the precursor ion to the collision cell, Q2, where the ion collide with a 
collision gas that fragments the ion. This is known as collision induced dissociation (CID). The 
resulting fragments enter the third quadruple, Q3, and one fragment at a time as scanned out 
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and sent to the detector. This provides structural information of the molecular ions and is the 
tandem system known as MS/MS.  
 
Figure 3-10: The triple quadrupole mass spectrometer. Q1 and Q3 are mass spectrometers 
and Q2 is the collision cell. Figure from Particle Sciences.  
 
The ionised molecules move through the quadrupoles by an oscillating electric-magnetic field. 
The speed at which the molecules travel is affected by their mass over charge ratio (m/z). The 
metal rods are placed to make opposing rods that have an equal but opposite DC voltage 
superimposed with a radiofrequency AC voltage. By alternating the voltage and 
radiofrequency, ions can travel in a straight spiral through to a detector or hit the rods. Hitting 
the rods is a way of removing undesirable ions, as they get neutralised. (Ho et al., 2003). This 
method represents multiple reaction monitoring (mrm) for detection and quantitation, where the 
Q1 and Q3 settings are set for a selected section of precursor and product ions. The 
chromatograms is based on the counts per second of fragment ions.  
Steroid profiling on sample media was carried out by LC-MS/MS at the Haukeland University 
Hospital, Bergen, Norway according to a method by Methlie et al. (2013), which was modified 
to quantitate all steroid hormones and their intermediate metabolites that are produced in the 
human adrenal gland. The modifications were done by Ralf Kellmann, in collaboration with 
Kareem Ahmed (not published).   
3.6.1 Sample extraction 
Calibrators, quality controls, and samples were extracted by liquid-liquid extraction on 
a Hamilton Star pipetting robot prior to LC-MS/MS analysis. A volume of 85 µl of each 
calibrator, quality control, and sample was transferred to a 96-well microtitre plate with 1.2 ml 
glass inserts. Subsequently, 10 µl internal standard (IS) solution was added to each well, during 
which each sample was mixed by 3 pipetting cycles of 50 µl. The plate was then incubated for 
one hour at room temperature to equilibrate possible interactions between isotopically labelled 
  
33 
 
steroids and binding proteins in the sample. After equilibration, 850 µl ethylacetate:hexane 
(80:20 % vol/vol) was added to each well, and samples were mixed with 15 pipetting cycles of 
850 µl. After phase separation, 650 µl supernatant was transferred from each sample to new 96-
well plate with glass inserts, and evaporated under a stream of nitrogen at 40°C. Finally, 
samples were reconstituted with 50 µl of 25% methanol. Calibrators, quality controls and IS 
are listed in Appendix C.  
3.6.2 LC-MS/MS  
LC-MS/MS analysis was carried out on a Waters Xevo T-QS triple quadrupole mass 
spectrometer that was coupled on-line to a Waters i-class Acquity UPLC. Ionisation was 
achieved by electrospray ionisation (ESI) in positive and negative mode.  
The following LC conditions were used. Chromatographic separation was achieved on a Waters 
Acquity BEH-C18 column (2.1 x 100 mm, 1.7 µm particle size, pore-size 130 Å). The column 
temperature was set at 60°C. The mobile phases consisted of mobile phase A and mobile phase 
B (Materials 2.10). The injection volume was 4 µl. Steroid hormones were detected and 
quantitated by isotope-dilution mass spectrometry by multi-reaction monitoring (mrm). 
Quantifier and qualifier mrm-transitions are given in Appendix C. MS data was analysed using 
Waters TargetLynx™ Application Manager.  
3.7 Isolation of mitochondria 
As many of the enzymes of interest in the steroidogenesis pathway are present in the 
mitochondria, mitochondria were isolated from the cells using sonication followed by 
differential centrifugation. Mitochondria were isolated using a sucrose buffer as described 
previously (B. J. Clark et al., 1994).  
3.7.1 Cell lysis by sonication 
The cell pellet were washed twice by adding 1 mL of ice cold 1xPBS (Materials 2.10) 
and centrifuged at 13000g for 5 minutes at 4℃. 200 µL sucrose lysis buffer with 1 mM PMSF, 
1 mM sodium orthovanadate and 1 mM protease inhibitor cocktail (Materials 2.10) was added 
to the cells and incubated on ice for 30 minutes. The cells were then sonicated on ice for 4 x 15 
seconds on at 60 Hz and 10 seconds off.    
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3.7.2 Organelle enrichment by differential centrifugation 
Organelle and isolation were performed based on methods described by B. J. Clark et 
al. (1994) and Poli et al. (2013). After sonication, the cell lysate was first centrifuged at 600 x 
g for 30 minutes at 4℃ to pellet heavy cell material, which then was discarded. The 
mitochondria-containing supernatant was transferred to a new centrifuge tube and further 
centrifuged at 13000g for 30 minutes at 4℃ to pellet mitochondria separated from the protein 
enriched supernatant. The mitochondria pellet were used for Western blot analyses, and the 
supernatant were used to measure protein concentration. Because of limited amount of 
mitochondria sample (not enough for both protein concentration measurement and Western 
blot), the protein amount of the mitochondria pellet was related to the protein concentration 
determined in the supernatant. The mitochondria pellet and protein supernatant were stored at 
– 80℃.   
3.8 Preparation of whole cell lysates 
Cell pellet were washed twice by adding 1 mL 1 x PBS and centrifuged at 13000 x g for 
5 minutes at 4℃, before 500 µL of RIPA buffer (Materials 2.10) was added to the pellet. Pellets 
were then sonicated on ice for 5 x 15 seconds on, and 10 seconds off, to break the cell wall. The 
cell lysate were then centrifuged twice at 13000 x g for 5 minutes at 4℃ to separate cell debris 
and the soluble protein fraction. Protein concentration was determined with Pierce™ 660 as 
described in chapter 3.9. 
3.9 Measurement of protein concentration 
The protein concentration of the supernatant was measured using the Pierce™ 660 nm 
protein assay. This dye consist of a reddish-brown low pH dye-metal complex that is negatively 
charged. When added to proteins, the dye will bind to positively charged amino acid groups, 
causing the dye to turn green. This changes the absorption maximum of the dye and protein 
concentration can be measured at 660 nm (Thermo Scientific). Bovine serum albumin diluted 
in sucrose lysis buffer was used to create a protein concentration standard dilution curve (Table 
3).  
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Table 3: Preparation of BSA protein standards 
 Blank  2000 
µg/mL 
 1000 
µg/mL 
500 
µg/mL 
250 
µg/mL 
125 
µg/mL 
62.5 
µg/mL 
Sucrose lysis buffer 100 µL 400 µL 100 µL 100 µL 100 µL 100 µL 100 µL 
BSA (10 mg/mL)  100 µL      
2000 µg/mL   100 µL     
1000 µg/mL    100 µL    
500 µg/mL     100 µL   
250 µg/mL      100 µL  
125 µg/mL       100 µL 
 
Protein measurements were performed in triplicates, and 10 µL of standards and unknown 
protein samples were added to separate wells on a 96 well Nunc clear micro plate. Next, 150 
µL of Pierce™ 660 reagent were added to each well and mixed gently by shaking for 1 minute. 
Then the plate was incubated for 5 minutes at room temperature protected from light. After 
incubation the absorbance was measured at 660 nm using an Enspire™ Multilabel Reader. The 
concentration of each unknown sample was calculated from the standard curve.  
3.10 Separation of proteins by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) 
Electrophoresis is movement of charged particles in an electric field. In SDS-PAGE, 
negatively charged proteins are separated based on molecular weight. The reducing agent β-
mercaptoethanol in the sample buffer (Material 2.10) denatures proteins by reducing disulphide 
binding. The detergent sodium dodecyl sulphate (SDS), which are a part of the gel, binds to 
protein samples to be separated and make the proteins negatively charged. This results in 
proteins with same shape and charge-to-mass ratio, leaving the molecular weight for each 
protein as the only variable.  
The polyacrylamide gel consist of long polymers of acrylamide cross-linked with N,N’-
methylenebisacrylamide. This cross-linked matrix resembles a grid that proteins travels 
through, and the density of this grid are determined by acrylamide concentration. Low 
concentration causes proteins to travel faster through the gel, and high concentration causes 
proteins to move slower. Small proteins travels faster through the gel than bigger proteins 
regardless of acrylamide concentration (Farrell et al., 2006).  
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3.10.1 Preparation of mitochondria samples 
The mitochondria pellets were dissolved in 50 µL of 1 x sample buffer (Materials 2:10) 
and sonicated (3 x 10 seconds on and 10 seconds off). Based on the protein concentrations 
calculated in the corresponding protein supernatants (chapter 3.7), approximately the same 
amounts of mitochondrial proteins were used from each sample. Samples were denatured (95℃ 
for 5 minutes), then quickly spun for 10 seconds and loaded onto the gel. The concentrations 
were calculated according to chapter 3.7, and the approximately amount of proteins loaded on 
the gels are listed in Table 4 (timeline), Table 5 (unstimulated) and Table 6 (stimulated).  
Table 4: Approximate quantities of samples from the timeline loaded onto 10 % SDS-PAGE 
gel 
 
Sample Quantity loaded (approx.) 
0 hour pooled mitochondria fragments 10 µg 
1 hour pooled mitochondria fragments 10 µg 
2 hours pooled mitochondria fragments 10 µg 
4 hours pooled mitochondria fragments 10 µg 
8 hours pooled mitochondria fragments 10 µg 
12 hours pooled mitochondria fragments 10 µg 
24 hours pooled mitochondria fragments 10 µg 
48 hours pooled mitochondria fragments 10 µg 
 
Table 5: Approximate quantities of samples loaded onto 10 % SDS-PAGE gel from 
unstimulated cells exposed to the mixture 
 
Sample Quantity loaded (approx.) 
DMSO control mitochondria fragment 4.2 µg 
DMSO control mitochondria fragment 4.2 µg 
DMSO control mitochondria fragment 4.2 µg 
1:106 mitochondria fragment 4.2 µg 
1:106 mitochondria fragment 4.2 µg 
1:106 mitochondria fragment 4.2 µg 
1:105 mitochondria fragment 4.2 µg 
1:105 mitochondria fragment 4.2 µg 
1:105 mitochondria fragment 4.2 µg 
1:104 mitochondria fragment 4.2 µg 
1:104 mitochondria fragment 4.2 µg 
1:104 mitochondria fragment 4.2 µg 
1:103 mitochondria fragment 4.2 µg 
1:103 mitochondria fragment 4.2 µg 
1:103 mitochondria fragment 4.2 µg 
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Table 6: Approximate quantities of samples loaded onto 10 % SDS-PAGE gel from stimulated 
cells exposed to the mixture 
 
Sample Quantity loaded (approx.) 
Forskolin control mitochondria fragment 4.2 µg 
Forskolin control mitochondria fragment 4.2 µg 
Forskolin control mitochondria fragment 4.2 µg 
1:106 mitochondria fragment 4.2 µg 
1:106 mitochondria fragment 4.2 µg 
1:106 mitochondria fragment 4.2 µg 
1:105 mitochondria fragment 4.2 µg 
1:105 mitochondria fragment 4.2 µg 
1:105 mitochondria fragment 4.2 µg 
1:104 mitochondria fragment 4.2 µg 
1:104 mitochondria fragment 4.2 µg 
1:104 mitochondria fragment 4.2 µg 
1:103 mitochondria fragment 4.2 µg 
1:103 mitochondria fragment 4.2 µg 
1:103 mitochondria fragment 4.2 µg 
3.10.2 SDS-PAGE 
Four µL of protein molecular weight standard were added to each gel. The electrical 
voltage was slowly increased, starting with 50 V for 5 minutes, then 80 V for 5 minutes, and 
then 100 V for 10 minutes until the proteins had migrated from the stacking gel into the 
separation gel. Then current was set at 180 V for approximately 50-60 minutes until the 
bromphenol blue front had reached the bottom of the gel. Samples from exposures and timeline 
were run on 10 % gels. Some of the pilot samples were run on 12.5 % gel, which is specified 
in the results or Appendix B. Parallel gels were stained with Colloidal Coomassie (Materials 
2.10) overnight, and destained (Materials 2.10) the next day to visualize proteins.  
3.11 Transfer of proteins to membrane by Western blotting 
Western blot is a method that is used to transfer proteins from a polyacrylamide gel onto 
a membrane through an electric current (Towbin et al., 1979). The membrane can be made of 
nitrocellulose, PVDF or other materials. After transferring proteins onto a membrane, proteins 
of interest can be detected using specific antibodies. Usually, the membrane is incubated with 
a primary antibody, which binds to the protein of interest. A primary antibody can be either 
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monoclonal or polyclonal. A monoclonal antibody is derived from a single B cell that only 
produces one specific antibody. A polyclonal antibody is less specific as antibodies are 
collected from serum instead of a cell. After primary antibody incubation, a secondary antibody 
are added onto the membrane that binds to the primary antibody. This secondary antibody are 
conjugated to an enzyme or fluorescence marker that makes the protein visible (Farrell et al., 
2006).  A common marker is horseradish peroxidase (HRP). Another marker used in this thesis 
is CyDye conjugated secondary antibodies, which are detectable when using fluorescence. 
3.11.1 Protein transfer to PVDF membrane optimized for fluorescence 
Originally, signal for cytochrome P450 enzymes were tested using secondary antibodies 
conjugated with CyDye, a fluorescent chromophore that can be detected with a Typhoon FLA 
9500 scanner. This requires the use of a low fluorescent PVDF membrane suitable for 
fluorescent scanning (Materials 2.8). A slightly modified protocol from the manufacturer (GE 
Healtcare) was followed. The PVDF membrane was pre-treated for 20 seconds in methanol to 
activate the membrane, washed for 20 seconds in dH2O and equilibrated for 15 minutes in cold 
1 x Transfer buffer (Materials 2.10). Membrane, pads and SDS-PAGE gel was equilibrated in 
cold 1 x Transfer buffer for 10 minutes prior to blotting. Protein transfer was executed for 2 ½ 
hours at 25 V in a 4℃ cold room.  
3.11.1.1 Immunological detection of proteins of interest 
After protein transfer, the membrane was washed twice in 1xTBST (Materials 2.10) for 
5 minutes. Then the membrane was blocked in 5 % dry milk TBST (Materials 2.10) for 45 
minutes at room temperature. After blocking, the membrane was rinsed twice in water and then 
washed 2 x 5 minutes in 1xTBST. The membrane was then incubated with a primary antibody 
diluted in 5 % dry milk TBST in 10 mL 1xTBST overnight at 4℃.    
Next day the membrane was rinsed twice in 1xTBST, then washed 2 x 5 minutes in 1xTBST. 
Membrane was probed with secondary antibody in a 1/2500 dilution in 10 mL 1xTBST without 
dry milk according to the manufacturer’s recommendation (Amersham), and incubated for 1 
hour in room temperature protected from light. After incubation, the membrane was rinsed 
twice in 1xTBST then washed 4 x 5 minutes in 1xTBST. Lastly, the membrane was rinsed 3 
times in 1xTBS before scanning using the Typhoon FLA 9500 scanner at a PMT value of 700 
V for wet membrane detection. Antibodies that were used with fluorescence detection are listed 
in Table 7.  
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Table 7: Overview of primary and secondary antibodies used for immunochemical detection 
of mitochondrial proteins by fluorescence.  
 
Primary antibodies Dilution  Secondary antibodies Dilution 
Anti-CYP11A1 1:1000 goat anti-rabbit Cy5 1:2500 
Anti-CYP11B2 1:1000 goat anti-rabbit Cy5 1:2500 
Anti-StAR 1:1000 donkey anti-goat Cy5 1:2500 
Anti-CYP19 (Aromatase) 1:1000 goat anti-rabbit Cy5 1:2500 
Anti-β-Actin 1:1000 goat anti-mouse Cy3 1:2500 
3.11.2 Protein transfer to PVDF membrane used for chemiluminescence  
For Western blot detection of enzymes from timeline and exposure experiments, 
chemiluminescence was favoured over fluorescence because of reaching higher sensitivity. 
This method does not require a PVDF membrane optimized for fluorescence detection, so 
another PVDF membrane was used instead (Materials 2.10). The PVDF membrane was pre-
treated for 20 seconds in methanol for activation of the membrane, washed for 20 seconds in 
dH2O and equilibrated for 15 minutes in cold 1 x Transfer buffer. Membrane, pads and SDS-
PAGE gel was equilibrated in cold 1 x Transfer buffer for 10 minutes prior to blotting. Protein 
transfer was performed for 1 hour, set at 100 V and 300 mA.  
3.11.2.1 Immunological detection of proteins of interest 
 After transfer, the membrane was washed twice in 1xTBST for 5 minutes. Unbound 
membrane was blocked with 5 % non-fat dry milk in 1xTBST for 45 minutes at room 
temperature, before the membrane was rinsed twice and then washed 2 x 5 minutes in 1xTBST. 
The membrane was then incubated with the primary antibody diluted in 0,05 % low-fat dried 
milk in 10 mL 1xTBST overnight at 4℃. Next day the membrane was rinsed twice and then 
washed 2 x 5 minutes in 1xTBST. Then the membrane was incubated with the HRP conjugated 
secondary antibody diluted in 5 % dry milk in 1xTBST for 1 hour in room temperature protected 
from light. After incubation, the membrane was rinsed twice and then washed 4 x 5 minutes in 
1xTBST. Prior to chemiluminescent detection, the membrane was washed for 5 minutes in 
deionized H2O. The membrane was incubated for 1 minute with a 1:1 mixture of SuperSignal
® 
West Femto Maximum Sensitivity Substrate and SuperSignal® West Pico Chemiluminescent 
Substrate (Materials 2.4). Chemiluminescent signals were detected using a ChemiDoc™ XRS+ 
imager. Antibodies used for chemiluminescence is listed in Table 8. 
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Table 8:  Overview of primary and secondary antibodies used for immunochemical detection 
of mitochondrial proteins by chemiluminescence. 
 
Primary antibodies Dilution  Predicted band 
size (kDa) 
Secondary antibodies Dilution 
Anti-CYP11A1 1:1000 60 HRP goat anti-rabbit 1:2500 
Anti-CYP11B2 1:1000 58 HRP goat anti-rabbit 1:2500 
Anti-CYP19 1:1000 58 HRP goat anti-rabbit 1:2500 
Anti-β-Actin 1:1000 42 HRP sheep anti-mouse 1:10000 
Anti-StAR - 37 Not available - 
 
3.11.3 Stripping of antibodies 
Membranes were sometimes stripped for bound antibodies and reprobed with another 
primary antibody, especially during antibody testing. After ended Western blot procedure, the 
membrane was washed in 1xTBS for 5 minutes in room temperature. Then the membrane was 
covered in stripping buffer (Materials 2.10), and incubated at 50 ℃ for 30 minutes while 
shaking. After stripping, the membrane was washed 2 x 5 minutes in 1xTBST before blocking 
and incubation with primary antibody.  
3.12 Separation of proteins by 2D-electrophoresis  
2D-electrophoresis is a method that separates proteins in two dimensions. In the first 
dimension, proteins are separated by isoelectric focusing. The second dimension separates the 
protein by molecular weight using SDS-PAGE (Liebler, 2000). The protocol described in 
Amersham Biosciences Ettan DIGE User Manual (Biosciences, 2002) was followed.  
3.12.1 Cell lysis by sonication and protein measurement 
Cell pellet were washed twice by adding 1 mL 1xPBS and centrifuged at 13000 x g for 
5 minutes at 4℃, before 600 µL of 2D-homogenisation buffer (Materials 2.10) was added to 
the pellet. Pellets were then sonicated on ice for 5 x 15 seconds on, and 10 seconds off, to break 
the cell wall. The cell lysate were then centrifuged twice at 13000 x g for 5 minutes at 4℃ to 
separate cell debris and the soluble protein fraction. Protein concentration was determined with 
Pierce™ 660 as described in chapter 3.9, but bovine serum albumin (BSA) was diluted in 2D-
homogenisation buffer to make the standard (Materials 2.10). 
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3.12.2 1D separation by isoelectric focusing (first dimension) 
In the first step of isoelectric focusing, proteins were transferred onto a 7 cm IPG strip 
by in-gel rehydration. 100 µL of sample containing 250 µg protein was mixed with 25 µL 5 x 
rehydration buffer (Materials 2.10) and pipetted onto a rehydration tray. The strip was placed 
face down onto the protein sample then added cover fluid to avoid dehydration. The IPG strip 
was left to rehydrate overnight in room temperature protected from light. The next day the 
isoelectric focusing was performed with an Ettan IPGphor 3 Isoelectric Focusing unit for 3 
hours.  
3.12.3 2D separation by SDS-PAGE (second dimension) 
As soon as the isoelectric focusing was done, the strip was put in a rehydration tray. 
Then 10 mL equilibration buffer A (Materials 2.10) was added to the strip, and shaken for 10 
minutes in room temperature before buffer A was discarded. The strip was incubated next with 
10 mL equilibration buffer B (Materials 2.10) for 10 minutes in room temperature while 
shaking.  After incubation, the IPG strip was soaked in the TGS running buffer (Materials 2.10) 
before placed on top of a 12 % SDS-PAGE gel (1.0 mm) for separating proteins by size. Four 
µl of the molecular weight standard was pipetted onto a small filter paper and placed next to 
the IPG strip. The top was sealed with 1 % agarose (Materials 2.10). The electrophoresis was 
run at 180 V until the dye front reached the bottom of the gel. The resulting gel was stained 
with Colloidal Coomassie (Materials 2.10) overnight, and destained (Materials 2.10) the next 
day to visualize proteins.  
3.13 Statistical analysis  
The statistical analyses of LC-MS/MS data from exposure experiments were performed 
in R using one-way Anova. Tukey multiple comparison test was performed when more than 
two samples indicated significant p-values. Statistical significance was set with a p-value at 
0.05. Intensity of antibody signal on the western blot was analysed with ImageJ. For each 
sample, the antibody signal for one enzyme was normalised with the β-actin signal 
(housekeeping protein) of the same sample. 
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4. RESULTS 
4.1 Establishing growth conditions for Y1 cells  
The Y1 cells did not grow according to recommended type of serum supplements, which 
were a combination of 2.5 % fetal bovine serum (FBS) and 15 % horse serum (American Type 
Culture Collection (ATCC) web site). Therefore, a different type of serum supplementation had 
to be considered. Yasumura et al. (1966) showed that Y1 cells need high serum concentration 
in order to maintain high steroid production, and in a relatively recent study, Whitehouse et al. 
(2002) used 10 % FBS to grow Y1 cells successfully. Taking these studies into account, 10 % 
charcoal stripped FBS was used as the only serum supplement to grow the Y1 cells. Charcoal 
stripping has previously been shown to efficiently remove hormones from serum (Cao et al., 
2009), and therefore charcoal stripped FBS was chosen to avoid interference from steroids in 
the serum supplement in the downstream steroid profiling analysis. Prior to use, the serum was 
analysed with LC-MS/MS, and the charcoal-stripped FBS were confirmed free of hormones 
(performed by Ralf Kellmann and Kareem Ahmed).  
Several papers report the cultivation of Y1 cells in Ham’s F10 medium (Colonna et al., 2005; 
Pagotto et al., 2014) or DMEM (Aumo et al., 2010; Whitehouse et al., 2002), or a combination 
of these. The medium used in this study was Ham’s F-12K (Kaighn’s) medium supplemented 
with 10 % FBS and 1 % Penicillin-Streptomycin (Pen-Strep). To monitor cell growth in this 
medium, pictures of cells were taken each day until cells reached 80-90 % confluence 
(approximately 4 days). While the cells initially were irregular shaped, their morphology 
changed into the characteristic epithelial shape two days after seeding (Fig. 4-1). This 
observation is in accordance to the descriptions given by ATCC (2015). Since the cells 
apparently grew as expected in 10 % FBS and HAM’s F-12K media, this growth media 
combination was used throughout the cell expansion procedure and for growing cells for 
exposure experiments (Materials 2.10).   
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Figure 4-1: Development of Y1 cells grown in Ham’s F-12K growth media supplemented 
with 10 % fetal bovine serum. Pictures show Y1 cells at 10x magnification on A) day one 
after seeding, B) day two after seeding, C) day three after seeding and D) day four after seeding. 
4.2 Choosing the sample buffer for SDS-PAGE protein separation 
based on antibody affinity testing  
4.2.1 Mitochondria enrichment or total protein cell lysates 
Many of the enzymes that are part of the steroidogenesis are found in the mitochondria, 
suggesting that mitochondria enrichment should be considered for optimal enzyme detection. 
Cells were lysed in either RIPA (whole cell lysates) or sucrose buffer (mitochondria 
enrichment). By using antibodies against various steroidogenic enzymes, the success and need 
for performing mitochondria enrichment would be indicated if antibodies only bound to 
mitochondria samples.  
Antibody specificity was tested on forskolin stimulated Y1 cells before the real exposure and 
time line samples were to be analysed in Western blots (chapter 3.11.2). In addition to Y1 cells, 
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human cell lines (HepG2 and H295R) have previously been shown to express some of the 
proteins of interest, and were therefore included as possible positive controls on the Western 
blots. The human hepatocytes, HepG2 cells, were lysed in RIPA, while human and mouse 
adrenocortical cells, H295R and Y1 cells, were lysed in either RIPA or sucrose buffer 
(Materials 2.10). Both the supernatant with soluble proteins and the mitochondria enriched 
pellet were loaded onto the SDS-PAGE gel. One sample of isolated Y1 mitochondria fraction 
lysed in RIPA was also added. This sample was prepared before the sucrose buffer was made, 
as a test to see if mitochondria could be isolated using RIPA buffer and differential 
centrifugation.  
Using an anti-CYP11B2 antibody, the mitochondrial protein CYP11B2 was detected in total 
protein fraction of human hepatocytes (HepG2 cells), as well as in total protein preparation 
(RL) and enriched mitochondria (SM) in human adrenocortical cells (Fig. 4-2). No CYP11B2 
were detected in Y1 cells. Thus, CYP11B2 could be detected in both total protein fraction and 
enriched mitochondrial fractions. 
 
Figure 4-2: Immunochemical detection of P450c11AS (CYP11B2) in HepG2, Y1 and 
H295R. Proteins separated on a 10 % SDS-PAGE gel. RM = RIPA isolated mitochondria. RL 
= RIPA whole cell lysate. SS = sucrose supernatant. SM = sucrose isolated mitochondria. 
Membrane was incubated with rabbit monoclonal anti-CYPB2 IgG primary antibody (1:1000) 
and detected with a goat anti-rabbit IgG HRP-conjugated secondary antibody (1:2000). 
Chemiluminescence was detected with a 1:1 mixture of SuperSignal® West Femto Maximum 
Sensitivity Substrate and SuperSignal® West Pico Chemiluminescent Substrate.  
 
CYP11A1, a protein located in the inner mitochondrial membrane with a molecular weight at 
60 kDa, was detected in human hepatocytes (HepG2), isolated Y1 mitochondria (Y1 RM), and 
in the enriched mitochondrial fraction of adrenocortical cells from mouse (Y1 SM) and both in 
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total protein and mitochondrial fraction of human cells (H295R RL and SM) (Fig. 4-3). Mouse 
CYP11A1 appeared to migrate slightly shorter than CYP11A1 from human cells. Thus, 
CYP11A1 could be detected in both total protein fraction and enriched mitochondrial fractions 
in the human cells, but only in the mitochondria fragment in Y1 cells. 
 
 
Figure 4-3: Immunochemical detection of P450scc (CYP11A1) in HepG2, Y1 and H295R. 
The membrane was incubated with rabbit polyclonal anti-CYP11A1 IgG primary antibody 
(1:1000) and detected with a goat anti-rabbit IgG HRP-conjugated secondary antibody 
(1:2000). Signal in Y1 marked with an arrow.  
 
The same membrane was stripped for 30 minutes and incubated with anti-CYP19. CYP19, a 
peripheral membrane protein with a molecular weight 58 kDa, was detected in total protein 
fraction, sucrose supernatant and enriched mitochondrial fraction of Y1 cells (Fig. 4-4) but not 
in human H295R cells. The antibody detected two proteins, one migrating according to a size 
of approximately 60 kDa, and one of 50 kDa. Thus, CYP19 could be detected in both total 
protein fraction and enriched mitochondrial fractions, meaning that Y1 cells can be lysed in 
RIPA and sucrose and there will be no difference regarding detection of CYP19.  
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Figure 4-4: Immunochemical detection of P450arom (CYP19 aromatase) in HepG2, Y1 
and H295R. The membrane was incubated with rabbit polyclonal anti-CYP19 IgG primary 
antibody (1:1000), and detected with a goat anti-rabbit IgG HRP-conjugated secondary 
antibody (1:2000). Signal for two bands marked with arrows.  
 
4.2.2 Using sucrose lysis buffer for mitochondria enrichment  
Since CYP11A1 could only be detected in the enriched mitochondrial fraction of Y1 
cells, and CYP19 and CYP11B2 were detected in either fraction, sucrose enrichment of 
mitochondrial fraction was used for the remaining Western blots of this study.  
4.2.3 Determining antibodies to use on exposed cells and timeline 
experiments 
Two antibodies appeared to work with the Y1 cells; the anti-CYP11A1 and anti-CYP19. 
These antibodies were therefore used on cells from the exposure experiments and cells from 
the timeline assays.  
CYP11B2 was decided to be tested on timeline cells in addition to the three antibodies. Signal 
for CYP11B2 was in the previous experiments only detected in the human cells, and this 
suggested that CYP11B2 were not present in Y1 cells. However, signal for CYP11B2 was 
tested on the timeline cells to investigate if this enzyme might be present in an earlier stage in 
the steroidogenic pathway.  
For Western blot detection of enzymes from timeline and exposure experiments, 
chemiluminescence was favoured over fluorescence because of reaching higher sensitivity. 
Relevant results from fluorescence immunological detection are listed in Appendix B. 
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4.3 Basal steroidogenesis in stimulated Y1 cells 
The basal steroidogenesis in Y1 cells were measured by three timeline experiments as 
described in chapter 3.3. This would help identify a suitable time window to measure 
metabolites in media in cells exposed to the mixture. Steroid profiling of media and enzyme 
levels in cells were studied with LC-MS/MS and Western blot.  
4.3.1 Immunological detection of steroidogenic enzymes  
During the 48h time line experiments, steroidogenic enzymes were detected using 
antibodies. Since Western Blot is semi-quantitative, this could reveal changes in enzymes 
concentrations over time as steroids are being produced in the cells. Cell samples for Western 
blot and parallel SDS-PAGE were prepared according to chapter 3.10 and Western blot were 
performed as described in chapter 3.11.  
 
From the parallel gel (Fig. 4-5) there seems to have been loaded more proteins from hour 1 and 
hour 4 on the gel. The same protein amounts were loaded on the gel used for Western blot and 
immunological detection. However, the membrane was incubated with anti-beta actin as a 
loading control, and were used for normalization of signal detection of CYP11A1 and CYP19. 
Because three samples from each time point were pooled together, difference in signal could 
not be analysed for statistical significance.  
 
Figure 4-5: Parallel SDS-PAGE gel of the samples collected in the timeline experiment. 
Mitochondria fraction of three pooled cell samples for each time point (0, 1, 2, 4, 8, 12, 24, 48 
hours, respectively) separated on a 10 % gel. Gel stained with colloidal coomassie for protein 
visualisation.  
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CYP19 was detected after 12, 24 and 48 hours. Two protein bands were detected that migrated 
according to masses of approximately 65 kDa and 50 kDa as previously detected (Fig. 4-6). 
Based on band intensity (Fig. 4-7), there seems to be slightly more CYP19 in the cells after 48 
hours.  
 
Figure 4-6: Immunochemical detection of P450arom (CYP19 aromatase) in Y1 cells. Three 
mitochondria enriched fractions were pooled for each time point (0, 1, 2, 4, 8, 12, 24, 48 hours, 
respectively) where transferred to a PVDF membrane. A universal antibody control was 
prepared by mixing whole cell lysates of forskolin stimulated H295R and Y1 cells. Membrane 
was incubated with rabbit polyclonal anti-CYP19 IgG primary antibody (1:1000) and primary 
antibody binding detected with a goat anti-rabbit IgG HRP-conjugated secondary antibody 
(1:2000). Chemiluminescence was detected with a 1:1 mixture of SuperSignal® West Femto 
Maximum Sensitivity Substrate and SuperSignal® West Pico Chemiluminescent Substrate.  
 
 
 
 
Figure 4-7: Band intensity of P450aro (CYP19). Band intensities were measured in ImageJ 
and signals were adjusted against beta actin. Band intensity represent the mean of the upper and 
lower band.  
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When the same membrane was stripped (chapter 3.11.3) and incubated with anti-CYP11B2, no 
CYP11B2 was detected in the timeline samples (Figure 4-8) except for in the antibody control 
that is probably binding of H295R as previously detected (Fig. 4-4). 
 
Figure 4-8: Immunochemical detection of P450c11AS (CYP11B2) in Y1 cells. 
Mitochondria enriched fractions of three pooled cell samples for each time point (0, 1, 2, 4, 8, 
12, 24, 48 hours, respectively) were transferred to a PVDF membrane. Antibody control is a 
mixture of forskolin induced H295R and Y1 whole cell lysates. Membrane was incubated with 
rabbit monoclonal anti-CYP11B2 IgG primary antibody (1:1000) and detected with a goat anti-
rabbit IgG HRP-conjugated secondary antibody (1:2000). 
 
The membrane was then incubated with anti-CYP11A1, and CYP11A1 were detected in all the 
cell samples in the time line. The membrane was then incubated with anti-beta actin. Figure 4-
9 shows the signals for both CYP11A1 and β-actin. Based in band intensity (Fig. 4-10), signal 
for CYP11A1 was strongest at 24 hours. As seen in the parallel gel, detection of β-actin showed 
more protein loaded from hour 1 and 4.   
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Figure 4-9: Immunochemical detection of P450scc (CYP11A1) and β-actin loading control 
in Y1 cells. Mitochondria enriched fraction of three pooled cell samples for each time point (0, 
1, 2, 4, 8, 12, 24, 48 hours, respectively) where transferred to a PVDF membrane. Antibody 
control is a mixture of forskolin induced H295R and Y1 whole cell lysates. Membrane was first 
incubated with rabbit polyclonal anti-CYP11A1 IgG primary antibody (1:1000) and detected 
with a goat anti-rabbit IgG HRP-conjugated secondary antibody (1:2000). Then the membrane 
was incubated with a mouse monoclonal anti-beta actin IgG primary antibody (1:1000) and 
detected with a sheep anti-mouse HRP-conjugated secondary antibody (1:10000). Black arrow 
is CYP11A1, grey arrow is β-actin.  
 
 
 
 
Figure 4-10: Band intensity of P450scc (CYP11A1). Band intensities were measured in 
ImageJ and signals were adjusted against beta actin.  
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4.3.2 Steroid profiling of metabolites in Y1 media 
Media collected from three timeline experiments with two replicates of each time point 
were analysed with LC-MS/MS (chapter 3.6). All time points were measured six times and 
absolute values is listed in Appendix A. One timeline was performed with longer incubation up 
to 72 hours. Results from this timeline is listed in Appendix D. 
Initially there were no detectable levels of pregnenolone until two hours after stimulation, and 
then concentrations increased slowly from 9 nM to 48 nM at eight hours. After twelve hours, 
the concentration increased quite rapidly from 152 nM to 411 nM at 24 hours before dropping 
down to 11 nM at 48 hours (Fig. 4-11). Pregnenolone is synthesised from cholesterol via 
CYP11A1, and is the rate-limiting step in steroidogenesis.  
 
 
Figure 4-11: Levels of pregnenolone in medium of forskolin stimulated Y1 cells.  
 
There were detectable levels of progesterone at time 0, and the concentration rapidly increased 
after two hours from 12 nM up to 619 nM at 24 hours, before decreasing to 74 nM after 48 
hours (Fig. 4-12). The concentration of progesterone were higher than pregnenolone for each 
time point, but the trend of pregnenolone and progesterone were similar with the highest 
concentration of both metabolites at 24 hours.  
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Figure 4-12: Levels of progesterone in medium of forskolin stimulated Y1 cells.  
 
 
Levels of 20α-dihydroxyprogesterone (20αOHP), one of the main metabolites produced in Y1 
cells, steadily increased in concentration after 12 hours (Fig. 4-13). There were low detectable 
levels of 20αOHP after 8 hours, which increased after 12 hours from 2 nM to 39 nM at 48 hours. 
The data from the timelines indicate linear increase of 20αOHP.  
 
 
 
Figure 4-13: Levels of 20α-dihydroxyprogesterone (20αOHP) in medium of forskolin 
stimulated Y1 cells.  
Corticosterone was detected after 12 hours, and concentration increased from 0.08 nM to 7.9 
nM at 48 hours of incubation (Fig. 4-14). Both end products, 20α-dihydroxyprogesterone and 
corticosterone, reached detectable levels in media after approximately 12 hours. Comparing the 
two metabolites, levels of 20α-dihydroxyprogesterone were higher than of corticosterone.  
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Figure 4-14: Levels of corticosterone in medium of forskolin stimulated Y1 cells.  
 
Androstenedione, an androgen, were detectable at time 0, However there was no clear trend of 
increasing concentration until after four hours (Fig. 4-15). Then concentration increased slowly 
from 0.94 nM to 2.2 nM at 48 hours.  
 
 
Figure 4-15: Levels of androstenedione in medium of forskolin stimulated Y1 cells.  
 
 
When quantifying testosterone with LC-MS/MS, an interference was detected in the mass 
spectrometry. This was shown as a widening of the peak in the mass spectrometry, as well as 
two peaks instead of one peak. However, since the interference were the same for all samples, 
the measured concentrations were comparable. Like with androstenedione, there were 
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detectable levels of testosterone from time 0. However, levels decreased from 0.08 nM at 1 
hour to 0.04 nM at 48 hours (Fig. 4-16).   
 
 
Figure 4-16: Levels of testosterone in medium of forskolin stimulated Y1 cells.  
 
Estradiol, an estrogen synthesised from androstenedione via CYP19, were detected after 24 
hours at 0.06 nM. Concentration increased to 1.2 nM at 48 hours (Fig. 4-17).  
 
 
Figure 4-17: Levels of estradiol in medium of forskolin stimulated Y1 cells.  
 
Estrone, an estrogen synthesised from testosterone via CYP19, were first detected after 24 hours 
at 0.03 nM (Fig.4-18). The concentration increased to 0.27 nM after 48 hours.   
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Figure 4-18: Levels of estrone in medium of forskolin stimulated Y1 cells.  
 
The measured concentrations of androgens (androstenedione, testosterone) and estrogens 
(estradiol, estrone) were much lower than the measured concentrations of 20α-
dihydroxyprogesterone and corticosterone.  
4.4 Testing the cytotoxicity of the four mixture doses 
The cytotoxicity of the diluted POP-mixture doses on the Y1 cells was tested using 
alamarBlue®. Not all the doses were tested for the unstimulated conditions because of limited 
amount of POP-mixture to make dilutions.  
As expected, Triton X-100 and media blank (positive controls) had low fluorescent 
intensity (Fig. 4-19). Measured fluorescence intensity was high in the negative control cells 
treated with normal growth media (12000 FL 590). Similar intensities were observed in 
unstimulated cells supplemented with 0.1 % DMSO, unstimulated exposed cells (1:103 mixture 
dilution), 0.1 % forskolin stimulated cells and exposed stimulated cells (1:103, 1:104 and 1:105 
mixture dilutions). This indicated that neither DMSO, forskolin nor the different POP-mixture 
concentrations were cytotoxic or induced apoptosis in Y1 cells.   
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Figure 4-19: Cell cytotoxicity test of the mixture after incubation with alamarBlue®. 
Fluorescence measured at 540 nm excitation and 590 nm emission using an Enspire™ 
Multilabel Reader. 
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4.5 Effects of the mixture of POPs on steroidogenesis in Y1 cells 
To study the effects on steroidogenesis in Y1 cells by contaminant mixtures, Y1 cells, 
either stimulated by forskolin or not, were exposed to the contaminant mixture. Subsequently, 
steroid profiling of media and enzyme levels in cells were studied with LC-MS/MS and Western 
blot.  
4.5.1 Effects in unstimulated cells  
The effects of the mixture in unstimulated cells were measured in three exposure 
experiments as described in chapter 3.5.1. 
4.5.1.1 Immunological detection for effects on steroidogenic enzymes  
 
Cell samples for Western blot and parallel SDS-PAGE were prepared according to 
chapter 3.10 and Western blot were performed as described in chapter 3.11.2.  
  
From the parallel gels (Fig. 4-20) there seems to have been loaded more protein from the 1:106 
sample from the first exposure. The same protein amounts were loaded on the gels used for 
Western blot and immunological detection. However, the membranes were incubated with anti-
beta actin as a loading control, and were used for normalization of signal detection of CYP11A1 
and CYP19.  
 
Figure 4-20: Parallel SDS-PAGE gels of unstimulated Y1 cells exposed to the mixture. 
Mitochondria fragment of one cell sample for each exposure (1st, 2nd and 3rd repeated exposure, 
respectively) run on two 10 % gel. Left to right is the lowest dose to the highest dose tested on 
the Y1 cells (1:106, 1:105, 1:104 and 1:103). Gels stained with colloidal coomassie for protein 
visualisation. 
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As expected, two proteins reactive to the anti-CYP19 antibody were detected in the Y1/H295R 
control (black and grey arrow). However, no CYP19 was detected in unstimulated Y1 cells or 
in non-stimulated cells exposed to the contaminant mixtures (Fig. 4-21).  
 
 
 
Figure 4-21: Immunochemical detection of P450arom (CYP19 aromatase) in 
unstimulated Y1 cells exposed to contaminant mixtures. Mitochondria fraction of one cell 
sample for each exposure (1st, 2nd and 3rd repeated exposure, respectively) transferred to PVDF 
membranes. Left to right is the lowest dose to the highest dose tested on the Y1 cells (1:106, 
1:105, 1:104 and 1:103). Antibody control is a mixture of forskolin induced H295R and Y1 
whole cell lysates. Membranes were incubated with rabbit polyclonal anti-CYP19 IgG primary 
antibody (1:1000) and detected with a goat anti-rabbit IgG HRP-conjugated secondary antibody 
(1:2000). Chemiluminescence was detected with a 1:1 mixture of SuperSignal® West Femto 
Maximum Sensitivity Substrate and SuperSignal® West Pico Chemiluminescent Substrate. 
 
 
The membranes were then incubated with anti-CYP11A1, and CYP11A1 was detected in all 
the samples (Fig. 4-22). The membranes were then incubated with anti-beta actin. Figure 4-22 
shows the signals for both CYP11A1 and β-actin. Based in band intensity but there was no 
significant difference between levels in unstimulated cells and cells exposures to the mixtures 
(Fig. 4-23). As seen in the parallel gels, detection of β-actin showed more protein loaded from 
the 1:106 sample from the first exposure compared to other samples on the same membrane. 
Nevertheless, the amount seems to be the same as loaded on the other membrane. However, 
detection of β-actin showed less protein loaded from the 1:106 sample from the second 
exposure.  
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Figure 4-22: Immunochemical detection of P450scc (CYP11A1) and β-actin loading 
control in unstimulated Y1 cells exposed to the mixture. Mitochondria fraction of one cell 
sample for each exposure (1st, 2nd and 3rd repeated exposure, respectively) transferred to PVDF 
membranes. Left to right is the lowest dose to the highest dose tested on the Y1 cells (1:106, 
1:105, 1:104 and 1:103). Antibody control is a mixture of forskolin induced H295R and Y1 
whole cell lysates. Membranes were first incubated with rabbit polyclonal anti-CYP11A1 IgG 
primary antibody (1:1000) and detected with a goat anti-rabbit IgG HRP-conjugated secondary 
antibody (1:2000). Then the membranes were incubated with a mouse monoclonal anti-beta 
actin IgG primary antibody (1:1000) and detected with a sheep anti-mouse HRP-conjugated 
secondary antibody (1:10000). Black arrow is CYP11A1, grey is β-actin.  
 
 
Figure 4-23: Band intensity for CYP11A1 in unstimulated Y1 cells exposed to the mixture, 
all doses included. Band intensities were measured in ImageJ and signals were adjusted against 
beta actin.  
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4.5.1.2 Steroid profiling for effects in metabolites  
For the unstimulated cells, only two metabolites where possible to quantify. Those were 
the two precursors, pregnenolone and progesterone (Fig. 4-26). The levels of progesterone in 
unstimulated cells were lower than that in stimulated cells (2.89 nM vs 148.09 nM). Moreover, 
the levels of pregnenolone and progesterone increased above the lowest detection limit at the 
highest concentration of contaminants used (Appendix C), indicating that some environmental 
toxicant in the mixture stimulated steroidogenesis. 
 
Figure 4-24: Measured levels of pregnenolone and progesterone in medium. There was 
detectable levels of A) pregnenolone in cells exposed to the two highest doses however. There 
is a significant increase in B) progesterone in cells exposed to the highest dose, p < 0,001.  
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4.5.2 Effects in forskolin-stimulated cells  
The effects of the mixture in unstimulated cells were measured in three exposure 
experiments as described in chapter 3.5.2. Y1 cells were inspected for cell rounding upon 
forskolin stimulation before and after exposures (Fig.4-25).  
 
Figure 4-25: Y1 cells stimulated with forskolin for exposure experiments. First picture is 
the first exposure before adding the mixture. Second picture is the second exposure before 
adding the mixture. Thrid picture is Y1 cells after mixture exposures for 48 hours. 10x zoom. 
Picture by Silje Kathrine Larsen.  
 
4.5.2.1 Immunological detection for effects on steroidogenic enzymes 
 
Cell samples for Western blot and parallel SDS-PAGE were prepared according to 
chapter 3.10 and Western blot were performed as described in chapter 3.11.2.  
  
From the parallel gels (Fig. 4-26) there seems to have been loaded less proteins from the 1:106 
and 1:105 samples both from the second exposure. The same protein amounts were loaded on 
the gels used for Western blot and immunological detection. However, the membranes were 
incubated with anti-beta actin as a loading control, and were used for normalization of signal 
detection of CYP11A1 and CYP19.  
 
  
62 
 
 
 
Figure 4-26: Parallel SDS-PAGE gels of stimulated Y1 cells exposed to the mixture. 
Mitochondria fraction of one cell sample for each exposure (1st, 2nd and 3rd repeated exposure, 
respectively) transferred to PVDF membranes. Left to right is the lowest dose to the highest 
dose tested on the Y1 cells (1:106, 1:105, 1:104 and 1:103). Antibody control is a mixture of 
forskolin induced H295R and Y1 whole cell lysates, and only added to the first parallel SDS-
PAGE gel due to restricted amounts of control. Gel stained with colloidal coomassie for protein 
visualisation. 
 
Based on the parallel gels (Fig. 4-26) there seems to be the same amount loaded on both gels 
of almost every sample. Detection of β-actin (Fig. 4-27) however showed more protein loaded 
on the second membrane containing samples exposed to the higher doses (1:104 and 1:103).  
 
 
Figure 4-27: Immunochemical detection of β-actin loading control in stimulated Y1 cells 
exposed to the mixture. Mitochondria fraction of one cell sample for each exposure (1st, 2nd 
and 3rd repeated exposure, respectively) run on a 10 % gel. Antibody control is a mixture of 
forskolin induced H295R and Y1 whole cell lysates. Membrane was incubated with mouse 
monoclonal anti-beta actin IgG primary antibody (1:1000) and detected with a sheep anti-mouse 
HRP-conjugated secondary antibody (1:10000). Chemiluminescence was detected with a 1:1 
mixture of SuperSignal® West Femto Maximum Sensitivity Substrate and SuperSignal® West 
Pico Chemiluminescent Substrate. 
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CYP19 was detected in the Y1/H295R-control sample, but not in Y1 cells stimulated by 
forskolin, nor in forskolin-stimulated cells co-exposed with contaminant mixtures at different 
concentrations (Fig. 4-28). The signal however was quite strong in the antibody control, so 
signal on the exposures and forskolin control might have been undetected due to saturation.  
 
Figure 4-28: Immunochemical detection of P450arom (CYP19 aromatase) in stimulated 
Y1 cells exposed to the mixture. Mitochondria fraction of one cell sample for each exposure 
(1st, 2nd and 3rd repeated exposure, respectively) transferred to PVDF membranes. Antibody 
control is a mixture of forskolin induced H295R and Y1 whole cell lysates. Membranes were 
incubated with rabbit polyclonal anti-CYP19 IgG primary antibody (1:1000) and detected with 
a goat anti-rabbit IgG HRP-conjugated secondary antibody (1:2000).  
 
Since CYP19 and CYP11A1 differ in size, the membranes were incubated with anti-CYP11A1 
without stripping to remove anti-CYP19. In cells from experiment 1 and 2, CYP11A1 (appr. 
75 kDa) was detected in forskolin-stimulated Y1 cells and in stimulated cells exposed to various 
concentrations of contaminant mixtures (Fig. 4-29). The signal intensity for exposure 1 was 
calculated in Figure 4-30. Because only samples from the first exposure were used analysing 
signal intensity, difference in signal could not be analysed for statistical significance.  
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Figure 4-29: Immunochemical detection of P450scc (CYP11A1) in stimulated Y1 cells 
exposed to the mixture. Mitochondria fraction of one cell sample for each exposure (1st, 2nd 
and 3rd repeated exposure, respectively) transferred to PVDF membranes. Antibody control is 
a mixture of forskolin induced H295R and Y1 whole cell lysates. Membranes were incubated 
with rabbit polyclonal anti-CYP11A1 IgG primary antibody (1:1000) and detected with a goat 
anti-rabbit IgG HRP-conjugated secondary antibody (1:2000). Black arrow is CYP11A1, grey 
arrow is the lower band of CYP19 which seems to become detectable.  
 
 
 
 
Figure 4-30: Relative quantification of CYP11A1 in Y1 cells. Band intensity of CYP11A1 
in exposure 1 was measured with ImageJ and signals were adjusted against beta actin.  
 
After incubation with CYP11A1, visible bands for CYP19 were still detectable on the blot 
(Figure 4-23, grey arrow) and band for CYP19 appeared in control samples and exposure 
samples. This might be due to more washing, making the anti-CYP19 binding more visible. As 
seen for CYP11A1, there were also some difference in band intensity between exposure 1, 2 
and 3 for CYP19. The strongest bands are the ones from exposure 1, at least in the membrane 
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with the controls. The band intensity was calculated based on the lower band at approximately 
50 kDa, since the band at approx. 65 kDa that had previously been detected in Y1 cells could 
not be detected on the blots in Figure 4-29. Because only samples from the first exposure were 
used analysing signal intensity, difference in signal could not be analysed for statistical 
significance (Fig.4-31). 
 
 
 
Figure 4- 31: Relative quantification of CYP19 in exposure 1. Band intensity of CYP19 in 
exposure 1 was measured with ImageJ and signals were adjusted against beta actin.  
 
 
Based on the difference in band intensity between the exposures (1, 2 and 3) it might indicate 
that the forskolin stimulation has been more successful in the first exposure, and something 
might have gone wrong with exposure 2 and 3.  
4.5.2.2 Steroid profiling for effects in metabolites 
The difference sin enzyme levels between the three independent experiments indicated 
that steroid production was induced to various degrees. Steroid profiling also showed difference 
between experiments; with stimulated cells in exposure 2 that showed no stimulation, data from 
exposure 3 show an irregular pattern and data from experiment 1 giving the most reliable 
results. Based on this, only the data from exposure 1 will be presented. The results from steroid 
profiling shows that cells exposed to the highest dose of the environmental pollutants increased 
steroid production. Five of eight steroids measured in media had significant increase in levels 
compared to forskolin controls.  
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In the Y1 cells, levels of progesterone was the highest measured metabolite followed by 20α-
dihydroxyprogesterone (20αOHP), pregnenolone and corticosterone (Fig. 4-32). This matched 
the basal steroid profile at 48 hours (chapter 4.3.2). All metabolites had elevated concentration 
levels in cells exposed to the highest mixture dose (1:103).   
 
 
Figure 4-32: Overview of main steroids produced in Y1 cells after 48 hour exposure.  
 
 
In Y1 cells exposed to the highest exposure dose of the mixture (1:103), the production of all 
four metabolites were significantly increased compared to the control (Fig. 4-33). Levels of 
progesterone was increased by 60 % compared to forskolin controls. The levels of 20α-
dihydroxyprogesterone was increased by 20 %. Pregnenolone levels had the highest increase in 
production with a 122 % elevated levels compared to the controls. The corticosterone levels 
was increased by 30 %.  There was no significant effects in cells exposed to the other doses.  
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Figure 4-33: Levels of main steroids produced in zona fasciculata in medium of stimulated 
Y1 cells exposed to the mixture for 48 hours. Control is cells only treated with forskolin 
(FSK). Pregnenolone A) had significant increased production in the highest dose, p < 0.001. 
Progesterone B) had significant increased production in the highest dose, p < 0.001. 20α-
dihydroxyprogesterone (20αOHP) C) had significant increased production in the highest dose, 
p < 0.01. Corticosterone D) had significant increased production in the highest dose, p < 0.001.   
 
 
For the androgens measured in the Y1 cells, androstenedione was the highest measured 
metabolite followed by estradiol, estrone and testosterone (Fig. 4-34). This also matched the 
basal steroid profile at 48 hours (chapter 4.5.2). Levels of androgens and estrogens appeared to 
be independent of exposure concentration.   
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Figure 4-34: Overview of androgens and estrogens in Y1 cells in exposure 1 after 48 hour 
exposure.  
 
Among the androgens and estrogens, only estradiol levels were significantly increased in cells 
exposed to the highest dose (Fig. 4-35). Levels of estratiol increased by 21 % compared to the 
controls. There was no significant effects in cells exposed to the other doses.  
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Figure 4-35: Levels of main steroids produced in zona reticularis in medium of stimulated 
Y1 cells exposed to the mixture for 48 hours. A: Androstenedione, there are no significant 
difference between the exposures and control. B: Testosterone, there are no significant 
difference between the exposures and control. C: Estradiol, significant increase in the highest 
dose, p < 0.01. D: Estrone, there are no significant difference between the exposures and 
control. 
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4.6 Pilot experiments on 2D-electrophoresis for Y1 cells 
2D-electrophoresis was originally chosen as a method for separating and analyse how 
all proteins in the cells would respond when exposed to contaminants, and not only the specific 
steroids involved in steroidogenesis. 2D-electrophoresis was performed as described in chapter 
3.12. The 2D electrophoresis was successful with good separation of proteins in the Y1 cells 
(Fig. 4-36). Due to time limitations, this method was not used further in this thesis for analysis 
of exposed samples.  
 
Figure 4-36: 2D electrophoresis of an untreated Y1 pilot sample. Whole cell sample of Y1 
lysed in 2D homogenisation buffer, and rehydrated onto a 7 cm IPG strip pH 4-7. 12.5% gel 
stained with colloidal coomassie for protein visualisation. 
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5. DISCUSSION 
The Y1 adrenocortical cell line is widely used for studying the pathways regulated by 
ACTH (Rocha et al., 2003) as Y1 remains responsive to ACTH. Because of this, many studies 
involving Y1 cells mostly focus on the effect of ACTH on gene expression (Schimmer et al., 
2006), cell cycle control (Rocha et al., 2003), cell proliferation (Mattos et al., 2005) and various 
diseases linked to abnormal adrenal gland functions. There are also studies using Y1 to 
investigate the effects of drugs on steroid production (Brion et al., 2011). The cell line is an 
important model to characterise regulation of gene expression in the adrenal cortex because of 
the cell lines amenability to transfection with exogenous DNA (Rainey et al., 2004).  
In this thesis, the aim was to study how a mixture of POPs would influence the steroid 
production in Y1 adrenocortical cells in a dose-response manner. Effects were detected in both 
unstimulated and forskolin stimulated cells exposed to the highest dose. The concentration of 
progesterone and pregnenolone were elevated in unstimulated cells, whilst most of the steroids 
were elevated in stimulated cells. The combination of the effects seen in both cell conditions 
may indicate that the POPs mixture has an inductive effect on Y1 cell steroidogenesis which 
may be additive or synergetic in cells stimulated with forskolin.    
5.1 The effects of the mixture in unstimulated cells  
Results from steroid profiling on exposure of unstimulated cells showed that levels of 
pregnenolone were increased when exposed to the two highest doses, and progesterone 
increased significantly when exposed to the highest dose. Event though concentrations 
increased, the levels were lower than what is produced in normal stimulated cells. This indicates 
that the mixture can induce pregnenolone and progesterone synthesis. However, there was no 
significant difference in the production of CYP11A1.  
Similar induction of steroidogeneis have been found in unstimulated H295R adrenocortical 
cells exposed to other mixtures of POPs. Montaño et al. (2011) extracted POPs from crude cod 
liver oil, commercial oil and industrial waste where PCBs was the main component, followed 
by DDTs. Mixtures from crude cod liver oil and industrial waste containing high concentration 
of POPs induced production of progesterone, cortisol, estradiol and testosterone. Only estradiol 
levels were induced by incubation with the commercial oil, which was the oil containing low 
levels of POPs. All mixtures however induced gene expression of enzymes (CYP11B1, 
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CYP11B2) and the adrenocortical receptor (M2CR). The authors concluded that PCBs in the 
mixture were associated with the induction of steroidogenesis.  
Compared to the results in this thesis, there was no detection of steroids produced later in the 
steroidogenic pathway (estradiol, corticosterone) in unstimulated Y1. This might be due to the 
doses used in the Y1 cells contained very low concentrations of PCBs compared to the high 
doses from cod liver oil and industrial waste that increased steroid production in the H295R 
cells (Montaño et al., 2011). This may indicate that high levels of PCBs in a mixture can induce 
steroid production more significantly. Nevertheless, there was increased metabolic activity in 
the H295R cells that was exposed to the commercial oil with low levels of PCBs and HCB. It 
is therefore likely that the metabolic activity in Y1 cells have increased as well, since the 
mixture induces pregnenolone and progesterone.  
The results from the cell viability test further support this hypothesis. The mixture did not cause 
apoptosis in the cells, however the cell activity was increased in cells exposed to the mixtures, 
and for stimulated cells the raised activity were significant. Another consideration is the 
difference in mixture compositions. The mixtures used by Montaño et al. (2011) did not contain 
perfluorinated compounds, which is the main component in the mixture used on Y1. Therefore, 
induction of pregnenolone and progesterone production in Y1 cells might be a combination of 
perfluorinated compounds and PCBs in the mixture.  
Increased steroid production has also been reported in H295R cells exposed to two mixtures of 
POPs from two polluted lakes by Zimmer et al. (2011). These mixtures contained similar POPs 
used in this thesis (HCB, HCHs, chlordanes, DDTs, PCBs, BDEs and HBCD). The results 
showed increased production of cortisol and estradiol and reduction on testosterone levels in 
H295R. The study also revealed upregulation of CYP11B1, CYP11B2 and CYP19A1 genes. The 
MC2R gene that encodes the ACTH receptor was upregulated even though the cells were not 
ACTH stimulated before exposures. The steroid responses overall was thought to be caused by 
PCBs and DDT in the mixture.  
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5.2 The effects of the mixture in forskolin stimulated cells  
Even though the effects of the mixture on unstimulated cells might be minimal, more 
effects was observed on stimulated cells exposed to environmental pollutants. The effects 
observed in stimulated Y1 cells are more similar to the effects seen in unstimulated H295R cells 
(Montaño et al., 2011; Zimmer et al., 2011). Five of eight steroids measured in media had 
significant increase in levels compared to forskolin controls. The steroid profile does not seem 
to have been inhibited by the pollutants in the mixture, as the measured amounts of steroids in 
exposed cells were similar to those measured in the timeline experiment. The levels of 
pregnenolone, progesterone, 20α-dihydroxyprogesterone and corticosterone and estradiol were 
significantly increased.  
Increased levels of estradiol in Y1 cells was found to be the only steroid with increased levels 
in H295R cells exposed to a mixture with low concentration of POPs (Montaño et al., 2011). 
Since basal levels of estradiol in H295R cells is low, estradiol was argued to be a sensitive 
endpoint for induction. Estradiol has also been found to slightly increase H295R cell 
proliferation (Jaroenporn et al., 2008), which may explain why there was a slight increase in 
metabolic activity (Montaño et al., 2011). Since the basal levels of estradiol in forskolin 
stimulated Y1 is low, the effects of estradiol may be the same in Y1 as in H295R even though 
estradiol was not induced in unstimulated Y1 cells. This increased that might explain why 
estradiol was the only estrogen with increased levels in stimulated cells. 
Induction of estradiol might be due to HCB in the mixture. This was the compound that was 
thought to contribute to induction of estradiol levels (Zimmer et al., 2011) when administered 
in lower concentrations than PCBs and DDTs in H295R cells, showing that observed effects 
are caused not only by the compounds with the highest concentrations.  
There are some studies on Y1 testing single compound and effects on steroidogeneis. Studies 
have been performed with forskolin stimulated Y1 cells to investigate CYP11B1 and 
corticosterone inhibition by single compounds with and without a methyl sulfone group (-
MeSo2). A study by Johansson et al. (1998) showed that p,p`-DDE, PCB 118 and PCB 153 did 
not affect corticosterone synthesis, but MeSo2-PCBs and MeSo2-DDEs inhibited CYP11B1 in 
Y1 cells. It was concluded that the methyl sulfone group was needed for inhibition of 
CYP11B1. Further studies of single compounds 3-MeSO2-DDE and o,p’-DDD added to 
forskolin induced Y1 cells showed to bind irreversibly on cells. It was suggested that forskolin 
is able to activate these pollutants via CYP11B1 (Hermansson et al., 2007). Since the mixture 
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in this thesis contains p,p`-DDE and some of the PCBs tested, these studies have shown that 
these compounds does not inhibit or affect steroidogenesis when tested in single doses in Y1 
cells. The pesticide p,p`-DDE have also been found not to affect steroidogenesis in the H295R 
cell line as well (Sanderson et al., 2002).   
Testing of single compounds in the H295R cell line has also resulted in increases in steroid 
production. Xu et al. (2006) tested single doses of four different PCBs (PCB 101, 110, 126 and 
149) on H295R cells, where all PCBs tested resulted in upregulation of steroidogenic enzymes 
with exception of CYP11A1 and CYP17. CYP17 is however not present in Y1 cells for 
comparison. Upregulation of steroidogenic enzymes were also observed when testing single 
polybrominated diphenyl esters (PBDEs) in H295R cells, where 5-OH-BDE-47 was found to 
induce CYP19 (He et al., 2008). PBDEs did not seem to effect the regulation of CYP11A1 
(Song et al., 2008).    
Upregulation of steroids was also detected on H295R cells exposed to PCB 118, 153 and 126 
(Kraugerud et al., 2010). Focusing on PCBs that are in the mixture, PCB 118 increased levels 
of estradiol, progesterone, cortisol (human glucocorticoid) and aldosterone, while PCB 153 
increased levels of estradiol and aldosterone but downregulated testosterone. In this study, the 
levels of testosterone were not significantly changed. Studies have found that some compounds 
are inhibitors of CYP19. One study showed that perfluorinated compounds (PFOS, PFOA and 
PFBS) were aromatase inhibitors in the human placental choriocarcinoma JEG-3 cell line 
(Gorrochategui et al., 2014). This is a different result than what have been observed in this 
thesis where CYP19 activity seems to have been raised in stimulated cells. There is no detection 
of CYP19 in the unstimulated Y1 cells in both control and exposures, so if perfluorinated 
compounds in the mixture have inhibited CYP19 is uncertain.  
There are groups of POPs where the effect on steroidogenesis are not fully understood or lack 
in published data. There is little data on effects by chlordanes, and in vitro effects of HCB have 
not been studied (Zimmer et al., 2011). Testing chlordanes on the human placental 
choriocarcinoma JEG-3 cell line showed to induce CYP19 in the cells (Laville et al., 2006).  
Data suggests that there might not be a correlation between low dose administration of a mixture 
and low dose exposure of a single compound. Administration of single compounds may not 
have an adverse effect in a system, but adverse effects are detected after low dose exposure to 
mixtures and vice versa (Fisher, 2004). The doses administered to Y1 in this thesis are low, and 
effects are observed in both unstimulated and stimulated cells. When testing different mixtures 
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in vitro, even though there is similarities in the composition of POPs, small differences in 
concentration or components in the mixture may change the effects observed (Zimmer et al., 
2011). The levels of perfluorinated compounds used in this mixture might be causing induction 
of pregnenolone and progesterone in unstimulated Y1 cells in the highest dose. Testing groups 
of perfluorinated compounds would be of interest in further testing to understand how the PFCs 
might affect steroidogenesis, both alone and in combination with PCBs.  
The results in this thesis show upregulation of steroidogenesis when administered with the 
highest dose and no evident sign of enzyme inhibition. These findings correspond with previous 
findings when testing single compounds of PCBs, chlordanes and DDE on enzyme gene 
expression or steroid production in the H295R cell line, as well of mixtures of similar POPs. 
Even though the results correspond with studies done on single compounds and mixtures, there 
might be other factors that are responsible for upregulation of steroidogenesis in Y1 that cannot 
be explained by individual chemical properties.  
It is important to note that the results from steroid profiling are based on three replicates from 
one exposure on stimulated cells. Detection of CYP11A1 in the first exposure showed a slight 
decrease in the highest dose and the lowest dose, and detection of CYP19 showed that there are 
upregulated levels of CYP19 in all the exposed cells compared to the control. Statistical 
significance could not be calculated since only cell samples from one exposure could be used 
for semi-quantification. Steroid profiling and western blots will have to be repeated to confirm 
the findings from the first exposure.  
5.3 Choice of exposure doses  
An interesting aspect of the levels of toxicants is what concentrations an effect can be 
observed, meaning the dose-response curve for this mixture of POPs on Y1 cells. There is a gap 
between the highest dose and the second highest dose, from no effect to a significant effect. 
Thus, it cannot be determined if the highest dose of the POPs tested is a possible threshold for 
increase in steroidogenesis. Based on not finding any significant difference between the control 
and the three other lower doses, adjusting to higher doses to see where effects are observed 
might be a suggestion for further determining the toxicity of the mixture.   
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5.4 Basal steroid production in stimulated Y1 cells 
In the steroidogenic pathway, the rate limiting step is the conversion of cholesterol into 
pregnenolone. Pregnenolone was detected in media eight hours after stimulation with forskolin. 
Pregnenolone is the precursor of progesterone, and progesterone was measured in cells at all 
time points. It is likely that pregnenolone was not detectable shortly after induction as most 
were used to synthesize progesterone. As the concentration of pregnenolone increases, more 
progesterone build up in the cell. The highest measured steroid was progesterone, which is the 
most abundant steroid in the Y1 cells (Brion et al., 2011).   
Increased levels of progesterone have also been shown in clones of ST5-L mouse cells induced 
with cAMP for 24 hours in culture media. The production varied depending on the clone type: 
1) basal high progesterone production which was minimally stimulated by cAMP, 2) low basal 
production of progesterone which increased 5-fold with cAMP stimulation, and 3) both basal 
and cAMP had minimal progesterone secretion (Compagnone et al., 1997). The results in this 
thesis correspond with what was observed in pattern 2, with low basal production that increased 
up to 24 hours.  
CYP11A1 was present in all timeline cells, and signal increased slightly over time. However, 
since samples from three replicates were pooled together, the results cannot be tested for 
statistical significance. The strongest signal was at 24 hours, which is the time when 
pregnenolone concentration was highest in the cells. This might indicate that the best time to 
measure CYP11A1 and pregnenolone activity is between 12 and 24 hours.  
5.4.1 Steroids produced in the zona fasciculata 
After 24 hours, the concentration of the end products increased in the cells, and the 
concentration of pregnenolone and progesterone decreased as more is being used to synthesise 
end products. As expected, 20α-dihydroxyprogesterone was more abundant in the Y1 cells than 
corticosterone. This suggests that the best time point to measure end products is after 24 hours. 
As is reported previously using in rat adrenal cells, CYP11B1 is not expressed in rat zona 
glomerulosa cells, but is expressed in zona fasciculata cells (Mukai et al., 1995). This supports 
why CYP11B2 was not detected in the Y1 cells, as Y1 cells mainly contains cells from zona 
fasciculata (Rainey et al., 2004). Also CYP11B1 is highly expressed in Y1 cells (Domalik et 
al., 1991), suggesting that corticosterone is synthesised by CYP11B1 via deoxycorticosterone. 
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The cells are producing corticosterone in stimulation with forskolin (Johansson et al., 1998), so 
cells should be tested for CYP11B1 signal in western blot. Since the have been no testing with 
CYP11B1 antibody in this thesis, the effect the mixture might have on CYP11B1 expression is 
unknown.  
A question that arises from this thesis is how corticosterone is synthesised from 
deoxycorticosterone when normal Y1 cells have a deficiency in the CYP21 enzyme (Parker et 
al., 1985). CYP21 is the enzyme that converts progesterone to deoxycorticosterone in mice 
(Fig. 1-5).  The same lack in CYP21 expression found in Y1 cells was found in a study by 
Mellon et al. (1994) to make new adrenocortical cell lines (ST5R and ST5L) from two 
transgenic female mice. Progesterone and deoxycorticosterone were detected, but there was no 
measurement of CYP21 mRNA. Further work by Compagnone et al. (1997) confirmed that 
ST5L clones produced progesterone and corticosterone and expressed CYP11A1 and 
CYP11B1, but no CYP21 was detected. The authors proposed a hypothesis that an unidentified 
enzyme converts deoxycorticosteone to corticosterone.  
5.4.2 Steroids produced in the zona reticularis 
Interestingly, there were low levels of androstenedione and testosterone detectable in 
cells at all time points. Estradiol is metabolised from testosterone via CYP19, and levels of 
estradiol were detectable and increasing even though testosterone levels were constant. CYP19 
was detected in western blots 12 hours after forskolin stimulation. This corresponds with the 
late synthesis of estrone and estradiol, which is metabolised from androstenedione and 
testosterone via CYP19. Some enzymes are being synthesized from target genes when cells are 
being stimulated with a steroid inducing compound (Introduction Fig 1-3). This delays 
conversion of the androgens into estrogens. These results suggest that effects on sex steroids in 
Y1 cells is best investigated after exposure for minimum 12 hours.  
5.4.3 Deciding length of exposure to POPs depends on steroids of interest 
How long to expose cells to the mixture seems to depend on the steroids of interest. 
Effects on early metabolites might be better studied after maximum 24 hours exposure when 
the activity is highest. Effects on late metabolites like corticosterone and sex steroids might be 
better studied after 48 hours exposure. However, there seems to be an intermediate at 24 hours, 
where there is a shift in expression of early and late steroids. However, results form timeline 
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lasting 72 hours showed that levels of pregnenolone and progesterone was highest after 30 hours 
(Appendix B). This might be taken into consideration for future exposures.  
The length of exposure was decided based on results from LC-MS/MS method on the first 
timeline. This reading was done before calibrators and internal standards were made for 
measuring steroids in adrenocortical cells, so these results were semi-quantitative. The first run 
of a timeline showed a continuous increase in end products after 48 hours, as well as 
pregnenolone. Progesterone was higher at 24 hours and levels went down after 48 hours. A 48 
hour exposure was chosen based on the increasing levels of end products.  
However, the results from the exposures on forskolin stimulated cells showed that the levels of 
pregnenolone and progesterone were the most upregulated, with increased production of 122 % 
and 60 %. These two steroids were the only elevated metabolites in exposed unstimulated cells. 
Taking both cell conditions and the common effects into consideration, the impact of the 
mixture might be involved around the early stages of the steroidogenesis. Therefore, it might 
be interesting to test shorter exposure times more suitable for detecting pregnenolone and 
progesterone in media and enzymes and factors involved early in the steroidogenic pathway 
(CYP11A1, StAR).   
5.5 Evaluation of steroid profiling 
The LC-MS/MS method used in this thesis is newly established at the Hormone 
Laboratory of Haukeland University Hospital (unpublished), based on LC-MS/MS previously 
established for measuring glucocorticoids and androgens in human serum (Methlie et al., 2013). 
This method was stablished for studying multiple steroids found in the H295R steroidogenic 
pathway, which is a cell line secreting steroids similar to the profile in humans than the Y1 cell 
line. Since this method is based on the H295R steroid profile, this method proved to be a 
powerful tool to measure steroids also in Y1 cells. Not all steroidogenic metabolites could be 
measured however, as there are some steroids not produced in H295R cells (e.g. 20α-
dihydroxypregnenolone) which have not been included in the calibrators as of yet (Appendix 
C). The standards have not been fully adjusted for errors when preparing calibrators (e.g. 
pipetting), meaning that the measured concentrations might deviate until the standards are fully 
calibrated.  
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5.6 Evaluation of Western blots 
The band size in for CYP11A1 in the western blots gave signal at approximately 75 kDa 
in a 10 % SDS-PAGE gel opposed to the theoretical value for 60 kDa for CYP11A1. However, 
during antibody testing signal for CYP11A1 have been observed at both 75 kDa and 50 kDa 
(Appendix B). The inconsistency of signal for CYP11A1 might be due to “gel shifting,” which 
can be common for membrane bound proteins and the reasons are not fully understood. 
However, a mechanism behind might be proteins have not been fully denatured, and thusly 
binding to SDS is not complete. Binding to SDS is necessary in order to negatively charge the 
proteins which enables proteins to migrate through the SDS-PAGE gel (Rath et al., 2009).   
The Cyp19 gene in mice encodes for 503 amino acid residues (Terashima et al., 1991) and the 
CYP19 enzyme have a molecular mass of 57.8 kDa. In all western blots, there was two bands 
visible for CYP19. To my knowledge, there have not been published studies where detection 
of two CYP19 bands have previously been shown. However, in a product photo of a CYP19 
antibody (LS-C312646) from LifeSpan Biosciences Inc. (Appendix D) shows two bands on a 
western blot from human placenta. Two CYP19 genes, cyp19a and cyp19b, have been detected 
in ovaries and brains in zebrafish, respectively (Chiang et al., 2001), but CYP19 is encoded by 
only one gene in both humans and mice. Since two bands are detected in both controls and 
exposed cells, it is unlikely that the bands could be explained by post-translational modification 
of CYP19 by the mixture. The unexpected detection of two CYP19 bands might be a subject 
for further studies.   
There was a lot of background noise in the western blots for stimulated cells, which is probably 
due to the incubation with CYP19. The first image of CYP19 in stimulated cells had positive 
detection off two bands in antibody control, but the rest of the blot had no detectable signal of 
CYP19. This could be due to the signal being oversaturated. Detection of CYP19 was possible 
after washing and incubation with CYP11A1. Extra washing steps might have improved on the 
signal for CYP19 by washing away excess secondary antibody, making the signal visible on all 
the samples. This is had an effect in the antibody control, where signal became less saturated. 
However, only the lower CYP19 band was possible to distinguish on controls and exposed cells.  
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5.7 Evaluation of experimental setup  
Results from timeline and exposures gave rise to evaluation of the exposure setup. There 
was also suggestions for how to improve the results or what other antibodies should be tested 
to investigate how the mixture affects steroidogenesis.   
5.7.1 Fixed DMSO concentration in unstimulated cells  
In the experiment for unstimulated cells, only the control cells were added 0.1 % DMSO 
in the media. When diluting the mixture to make the four doses to be used on unstimulated 
cells, DMSO was not added to the dilutions. This was a mistake discovered after all three 
replicates were completed. All doses should ideally have been added 0.1 % DMSO as was done 
with the control. By adding 0.1 % DMSO in both control and exposures, the only variable to 
explain possible deviations from the control would be the mixture. This was not an issue with 
stimulated cells. Forskolin at a fixed concentration of 0.1 % forskolin was added to all doses 
and control for stimulated cells.  
5.7.2 Using forskolin to induce steroidogenesis   
Upon forskolin stimulation the cell shape got the characteristic rounded cell shape, 
which is a well known response to forskolin (Whitehouse et al., 2002). The change in cell shape 
was observed on all cells stimulated with forskolin used for pilot samples, timeline and 
exposures (Appendix A). However, the combined results from western blots and LC-MS/MS 
turned out to be an important tool to determine if the cells indeed had been stimulated.  
The results from steroids profiling initially showed that steroids were being produced in two of 
the repeated exposures, exposure 1 and 3. Exposure 3 had irregular pattern of steroid 
concentration, which were either lower or much higher than levels measured in exposure 
number one and timeline experiments. The second exposure, exposure 2, showed no indication 
of steroid production since levels were the same as found in untreated DMSO control cells. 
Based on steroid profiling, exposure 1 and 3 seemed to have been successful. However, results 
of the western blots gave indication of inefficient forskolin stimulation. Studying the forskolin 
induced controls on CYP11A1 detection (Fig.4-29), the signal was strong in the sample from 
exposure 1, weaker in exposure 2 and barely detectable in exposure 3 and the same trend are 
observed in the exposures. From immunodetection in exposed unstimulated cells (Fig. 4-22), 
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CYP11A1 is present in cells in a dormant state, which might explain that CYP11A1 are detected 
in exposure 2 and 3. Since there was correlation between the signal in the controls and 
exposures, it was likely that the results were due to the forskolin rather than an inhibition of 
steroidogenesis due to the mixture. Based on this, even though cells seem to have reacted to 
forskolin and steroidogenesis have started, this alone might not indicate that cells are producing 
steroids.  
One cause of failed steroidogenesis might be a combination of human failure and too many 
thaw-freeze cycles of forskolin. The first exposure were stimulated with forskolin that had not 
been thawed previously, and the results seem to show that this exposure have been successful. 
Exposure 2 and 3, which were unsuccessful, the same vial of forskolin was used. Consequently, 
forskolin should be used fresh in order to prevent contamination and loss of properties.  
 
5.7.2.1 Difference in using forskolin compared to ACTH 
Differences between forskolin and ACTH have been described previously in Y1 cells 
stimulated to forskolin or ACTH (Schimmer et al., 1985). Steroid production were measured 
over a six hour period, and the production of steroids increased three-fold in response to either 
compound. Therefore, using forskolin instead of ACTH to stimulate Y1 cells does not seem to 
make a difference in steroid production in the cells. However, the steroid production were 
measured for six hours, which is shorter than the time line for 48 and 72 hours in this thesis.  
As mentioned in chapter 5.1, elevated levels of the MC2R gene was measured in unstimulated 
H295R cells exposed to mixtures of POPs (Zimmer et al., 2011), a response that was thought 
to be related to PCBs in the tested mixtures. The authors argued that upregulation of the MC2R 
gene was not responsible for raise in hormone levels measured in the H295R cells, but might 
increase responsiveness to ACTH. One of the advantages in using Y1 is the intact ACTH 
receptor (same as MC2R). In the HPA axis in humans and rodents, ACTH is the main hormone 
that binds to the ACTH receptor in the cell surface (Tsigos et al., 2002). Therefore, using ACTH 
would be a more biologically accurate in vitro model to the steroidogenesis in vivo, and would 
be a way to investigate if the mixture acts like a ligand to the ACTH receptor. Since forskolin 
does not bind to the ACTH receptor, it is impossible to indicate if the increase in steroid 
production is due to binding to the ACTH receptor. Using ACTH would be interesting as a 
refinement to the experiment to see if some of the POPs binds to the ACTH receptor. However, 
there are reported Y1 mutants that are not responsive to ACTH (Schimmer et al., 1995) and the 
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current Y1 passage at ATCC is unresponsive to ACTH (Rainey et al., 2004), so steroid 
production should be tested before doing exposure experiments to ensure that Y1 cells react to 
ACTH stimulation.  
5.7.3 Immunological detection of StAR 
During antibody testing using fluorescence (Appendix B), StAR and CYP11A1 were 
not detected. A disadvantage of using fluorescence is that signal is dependent on amount of 
secondary antibody, and some proteins might require higher concentration of secondary 
antibody in order for a signal to be detected. Using chemiluminescence, which involves an 
enzymatic reaction for immunodetection, signal might be easier to detect by using sensitive 
substrates. This was the case with CYP11A1, as signal for CYP11A1 were observed with 
chemiluminescence. Unfortunately, signal for StAR was not possible to test with 
chemiluminescence, as a suitable HRP-secondary antibody was not available. However, 
considering that CYP11A1 was detectable using chemiluminescence, this method might be a 
good option for detection of StAR.  
5.8 Conclusions 
The production of pregnenolone and progesterone were upregulated in unstimulated 
cells exposed to the highest dose of the mixture of POPs. The production of CYP11A1 were 
slightly elevated, but there was no significant difference between the dose mixtures and the 
controls. CYP19 was not detected in neither control nor the dose mixtures, suggesting that the 
mixture did not induce CYP19 production. This was confirmed by not detecting the CYP19 
metabolised estradiol and estrone in media. However, the due to the detection limit of the LC-
MS/MS method the levels might be too low to measure in the current method. Previous studies 
have shown upregulation of genes involved in steroidogenesis encoding steroidogenic enzymes 
(e.g. CYP11A1 and CYP19) in H295R cells exposed to low dose mixture, but these 
upregulations were not detected in protein levels (Montaño et al., 2011). Therefore the effects 
on POPs in unstimulated cells might be of interest to investigate in further studies, especially 
regarding the composition of persistent organic pollutants in the mixture in regards to testing 
individual groups (e.g. perfluorinated compounds).  
The production of most steroids measured in media were upregulated in forskolin-stimulated 
cells exposed to the highest dose of the mixture of POPs in one of three exposures measured. 
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The steroids that were upregulated included pregnenolone, progesterone, 20α-
dihydroxyprogesterone, corticosterone and estradiol in all triplicates of one exposure. The 
production of CYP11A1 appeared unaffected, and signal for CYP19 in cells exposed to all 
mixture doses appeared to be elevated. Statistical analysis could not be performed for enzyme 
detection due to only one exposure being reliable for semi- quantitative analysis. Repetition of 
exposures will have to be conducted to confirm the effects of the mixture in stimulated cells.  
Nevertheless, the results indicated a synergetic or additive effect of the POPs mixture in 
forskolin-stimulated cells. These results are similar to studies on unstimulated H295R cells 
exposed to a higher concentrated mixture of POPs resulting in increased gene expression of 
steroidogenic enzymes and steroid production (Zimmer et al., 2011).  
5.9 Future perspectives  
A further step to investigate which compounds contribute to the increase of steroids 
would be to test the effects of individual pollutant groups. The most abundant group in the 
mixture, the perfluorinated compounds, would be of interest as there are lacking data of how 
they interfere with steroidogenic cells. Existing data of perfluorinated compounds shows 
evidence of enzyme inhibition, which is not found in this thesis.  An important modification to 
the method would be to stimulate Y1 cells with ACTH to investigate how the POPs would 
compete with an ACTH receptor ligand. The mixture might also affect other cell components 
and enzymes unrelated to steroid synthesis, which have not been measured in this thesis. One 
suggestion for obtaining more information on mechanisms would be shorter exposures, in 
combaination with analyses of the proteome and the genome.  
One way of investigating a wider effect on the proteome would be analysis with 2D 
electrophoresis, which would separate all proteins within the cells. Combined with gel analysis 
of up or downregulated protein proteins affected by the mixture can be identified by protein 
sequences. The 2D electrophoresis tested for use with Y1 cells in this thesis and is ready to be 
used for further analyses. A protein that could be interesting to investigate further is the CYP19 
enzyme. The two protein bands could be analysed by MS/MS to see if there is a difference in 
sequence between the two bands, or whether or not CYP19 have been modified by 
phosphorylation. Studies are being performed using in vivo models exposed to mixtures and 
single compounds, as well as other in vitro models. Studying the wider physiological impact of 
POPs in relation to stress will be of high relevance in the future.  
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APPENDIX A 
 
Table A 1: Levels of steroids measured in exposures on stimulated cells  
 
 Pregnenolone Progesterone 20α-OHP Corticosterone Androstenedione Testosterone Estradiol Estrone 
Control 17.75±6.14 148.09±18.68 40.12±1.21 6.89±0.18 2.29±0.10 0.05±0.003 1.20±0.05 0.33±0.02 
1/106 17.49±0.97 141.86±9.75 38.51±1.92 6.89±0.16 2.26±0.06 0.05±0.004 1.29±0.15 0.31±0.03 
1/105 19.03±2.35 134.87±7.39 41.24±1.09 7.12±0.10 2.34±0.05 0.05±0.003 1.35±0.10 0.38±0.04 
1/104 19.26±3.64 155.98±15.10 39.86±2.42 6.87±0.14 2.35±0.07 0.05±0.003 1.23±0.02 0.32±0.02 
1/103 39.55±5.69 238.19±20.49 48.72±2.06 8.24±0.03 2.30±0.08 0.05±0.004 1.46±0.05 0.35±0.02 
 
 
Table A 2: Levels of steroids measured in exposures on unstimulated cells 
 
 Pregnenolone Progesterone 
Control 0 2.89±0.37 
1/106 0 2.63±0.39 
1/105 0 2.53±0.38 
1/104 3.58±0.32 3.05±0.15 
1/103 3.98±0.58 4.35±0.29 
 
Table A 3: Levels of steroids measured in timeline from 48 and 72 hour timelines 
 
Time 
(h) 
Pregnenolone Progesterone 20α-OHP Corticosterone Androstenedione Testosterone Estradiol Estrone 
0 0 0.13±0.08 0 0 0.84±0.26 0.08±0.03 0 0 
0.5 0 0.65±0.22 0 0 0.74±0.23 0.08±0.01 0 0 
1 0 1.35±0.41 0 0 0.88±0.14 0.08±0.01 0 0 
2 8.93±2.50 12.05±3.79 0 0 0.76±0.12 0.08±0.01 0 0 
4 13.20±6.22 30.56±8.03 0 0 0.95±0.24 0.08±0.02 0 0 
8 48.63±6.70 160.23±28.08 0.06±0.04 0 1.18±0.20 0.07±0.02 0 0 
9 88.89±2.06 263.96±2.97 0.26±0.003 0 1.44±0.06 0.11±0.005 0 0 
12 176.02±56.69 462.38±106.09 2.05±1.53 0.06±0.01 1.44±0.25 0.08±0.02 0 0 
24 513.47±201.15 720.17±196.72 36.89±16.22 1.49±0.28 1.80±0.29 0.07±0.02 0 0 
30 984.03±42.26 1077.84±6.45 117.92±0.44 4.92±0.38 2.29±0.004 0.11±0.0007 0.09±0.05 0.01±0.01 
48 36.55±46.38 142.28±126.29 55.65±30.86 8.81±2.29 2.31±0.33 0.05±0.02 1.21±0.53 0.28±0.11 
54 38.56±7.07 141.27±11.12 85.86±2.39 12.00±0.38 2.58±0.08 0.06±0.001 1.52±0.12 0.33±0.01 
60 32.05±2.55 110.57±12.41 85.43±0.02 12.28±0.18 2.66±0.07 0.07±0.0001 1.49±0.11 0.35±0.01 
72 32.70±4.96 68.81±3.61 86.00±5.67 13.61±0.19 2.93±0.07 0.06±0.003 1.74±0.08 0.40±0.002 
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Table 9: Signal intensity in exposed stimulated cells  
 
Exposure 1 CYP11A1 CYP19*  β-actin 
Control 1.89777744 0.79571426 3771.154 
1/106 1.69172332 1.6800051 8196.64 
1/105 1.85402318 1.49750345 9516.326 
1/104 1.83163618 1.1006173 11035.518 
1/103 1.57748671 1.3056707 11254.569 
* 50 kDa 
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APPENDIX B 
This appendix includes the testing with CyDye conjugated secondary antibodies. All 
membranes were wet scanned for fluorescence signal at 700 V in Typhoon. Figure B1 and B2 
shows the variance in CYP11A1 migration on SDS-PAGE gels, with signal for CY11A1 at 
both approximately 50 and 75 kDa.  
 
Figure B 1: Fluorescent detection of P40scc (CYP11A1) in Y1 and H295R cells. RS = Ripa 
supernatant (without mitochondria). RM = Ripa mitochondria, mitochondria isolated in Ripa 
buffer. SS = Sucrose supernatant (without mitochondria). Membrane was incubated with rabbit 
polyclonal anti-CYP11A1 IgG primary antibody (1:1000) overnight at 4℃ and detected with 
anti-rabbit Cy5 secondary antibody (1:2500). There was a detected signal for Y1 and H295R, 
but at different band sizes indicated with arrows. The Y1 cells are untreated, and the H295R 
cells have been stimulated with forskolin.  
  
 
Figure B 2: Fluorescent detection of P40scc (CYP11A1) in HepG2, H295R and Y1 cell 
lines. Membrane was incubated with fresh rabbit polyclonal anti-CYP11A1 IgG primary 
antibody (1:1000) overnight at 4℃ and detected with anti-rabbit Cy5 secondary antibody 
(1:2500). Signal for CYP11A1 indicated with arrows.  
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Testing anti-beta actin on RIPA whole cell lysate (RL) and mitochondria isolated pellet (SM) 
and the protein supernatant (SS) showed that beta-actin was not detected in the SS (Fig. B 3). 
Beta actin could be used for protein loading quantification in RIPA whole cell lysates and 
mitochondria enriched pellet.  
 
Figure B 3: Multiplex fluorescent detection of P450c11AS (CYP11B2) and StAR in 
HepG2, H295R and Y1 cell lines. Membrane was incubated with rabbit monoclonal anti-
CYPB2 IgG primary antibody (1:1000) and goat anti-StAR (1:1000). Signal was detected with 
goat anti-rabbit Cy5 and donkey anti-goat Cy5 secondary antibodies, respectively. Black arrow 
indicate CYP11B2 just below 50 kDa. Grey arrow indicate β-actin. No detection of StAR. 
Picture taken with Cy5. β-actin is visible on Cy5 even though the β-actin secondary antibody 
is Cy3. The membrane was wet scanned for fluorescence signal at 700 V in Typhoon. 
 
 
 
Figure B 4: Incubation of anti-CYP19 detected in human placenta tissue lysate. Two bands 
are visible on the blot as seen with incubation of CYP19 in this thesis. Antibody epitope aa485-
503. Catalogue no. LS-C312646. Figure from LifeSpan BioSciences (2015).  
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APPENDIX C 
Tables and method description provided by Ralf Kellmann. 
 
Table C 1: MS method 
 
Metabolite Q1 Q3 Dwell 
time (s) 
Cone 
(V) 
CE eV Period 
start 
(min) 
Period 
end 
(min) 
 
Estrone sulfate 349.1235 145.0585 0.034 2 52 0 1.4 qualifier 
Estrone sulfate 349.1235 269.0857 0.034 2 30 0 1.4 quantifier 
Estrone sulfate-d4 353.17 147.05 0.034 2 50 0 1.4 qualifier 
Estrone sulfate-d4 353.17 273.2 0.034 2 32 0 1.4 quantifier 
DHEA sulfate 367.1681 79.956 0.034 12 76 0 2.5 qualifier 
DHEA sulfate 367.1681 96.9341 0.034 12 30 0 2.5 quantifier 
DHEAS-d6 373.2 80.01 0.034 10 70 0 2.5 qualifier 
DHEAS-d6 373.2 98 0.034 10 31 0 2.5 quantifier 
Estriol 287.15 145.05 0.072 26 42 2.5 3.1 qualifier 
Estriol 287.15 171.05 0.072 26 36 2.5 3.1 quantifier 
13C3-estriol-272 290.18 148.15 0.072 10 40 2.5 3.1 qualifier 
13C3-estriol-272 290.18 174.15 0.072 10 35 2.5 3.1 quantifier 
Aldosterone 359.025 189.0408 0.046 2 18 3.1 3.7 quantifier 
Aldosterone 359.025 331.1674 0.046 2 16 3.1 3.7 qualifier 
Aldosterone-d8 367.2 194.27 0.046 10 18 3.1 3.7 quantifier 
Aldosterone-d8 367.2 304.24 0.046 10 14 3.1 3.7 qualifier 
Cortisone 329.25 123.1 0.046 40 25 3.4 4.5 qualifier 
Cortisone 329.25 137.08 0.046 40 26 3.4 4.5 quantifier 
Cortisol 331.25 282.15 0.047 10 25 3.75 4.5 qualifier 
Cortisol 331.25 297.2 0.047 10 19 3.75 4.5 quantifier 
D4-cortisol 335.3 286.15 0.047 10 25 3.75 4.5 qualifier 
D4-cortisol 335.3 301.2 0.047 10 21 3.75 4.5 quantifier 
Corticosterone 347.15 97.08 0.047 15 31 4.5 5.05 qualifier 
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Corticosterone 347.15 121.05 0.047 15 18 4.5 5.05 quantifier 
11-deoxycortisol 347.2365 97.0961 0.047 2 24 4.5 5.1 quantifier 
11-deoxycortisol 347.2365 109.1361 0.047 2 26 4.5 5.1 qualifier 
D2-11DOC 349.2042 97.0993 0.047 2 24 4.5 5.1 quantifier 
D2-11DOC 349.2042 109.0748 0.047 2 26 4.5 5.1 qualifier 
Estrone 269.1425 145.0776 0.034 2 34 5.1 5.45 quantifier 
Estrone 269.1425 183.131 0.034 2 32 5.1 5.45 qualifier 
D4-estrone 273.21 147.08 0.034 8 38 5.1 5.45 quantifier 
D4-estrone 273.21 187.14 0.034 8 36 5.1 5.45 qualifier 
Estradiol 271.2 145.05 0.034 25 39 5.1 5.45 quantifier 
Estradiol 271.2 183.07 0.034 25 39 5.1 5.45 qualifier 
D4-estradiol 275.2 147.16 0.034 25 38 5.1 5.45 quantifier 
D4-estradiol 275.2 187.1 0.034 25 37 5.1 5.45 qualifier 
Androstenedione 287.1765 97.0994 0.026 4 20 5.45 5.8 quantifier 
Androstenedione 287.1765 109.0729 0.026 4 22 5.45 5.8 qualifier 
D7-
Androstenedione 
294.16 100.1 0.026 2 22 5.45 5.8 quantifier 
D7-
Androstenedione 
294.16 113.12 0.026 2 26 5.45 5.8 qualifier 
21OHP 331.15 97.05 0.026 25 22 5.6 6 quantifier 
21OHP 331.15 109.05 0.026 25 21 5.6 6 qualifier 
Testosterone 289.1965 97.1004 0.021 6 22 5.65 6.1 quantifier 
Testosterone 289.1965 109.1375 0.021 6 24 5.65 6.1 qualifier 
D3-Testosterone 292.1681 97.0436 0.021 56 20 5.65 6.1 quantifier 
D3-Testosterone 292.1681 109.0863 0.021 56 24 5.65 6.1 qualifier 
17OHP 331.1958 97.1009 0.021 8 22 5.95 6.4 quantifier 
17OHP 331.1958 109.1398 0.021 8 26 5.95 6.4 qualifier 
17-OHP-13C3 334.2958 100.1032 0.021 10 26 5.95 6.4 quantifier 
17-OHP-13C3 334.2958 112.142 0.021 10 30 5.95 6.4 qualifier 
DHEA 271.2 213.18 0.021 20 16 6 6.4 qualifier 
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DHEA 271.2 253.17 0.021 20 12 6 6.4 quantifier 
DHEA-d6 277.25 219.39 0.021 10 18 6 6.4 qualifier 
DHEA-d6 295.25 258.3 0.021 10 10 6 6.4 quantifier 
Dihydrotestosterone 291.2 159.1 0.048 30 20 6.3 6.95 qualifier 
Dihydrotestosterone 291.2 255.2 0.048 30 15 6.3 6.95 quantifier 
Progesterone 315.1088 97.043 0.047 4 20 6.95 7.6 quantifier 
Progesterone 315.1088 109.1432 0.047 4 28 6.95 7.6 qualifier 
Pregnenolone 317.2 159.13 0.047 24 24 7.25 9.45 quantifier 
Pregnenolone 317.2 281.23 0.047 24 14 7.25 9.45 qualifier 
D9-Progesterone 324.2319 100.0929 0.047 10 20 6.95 7.6 quantifier 
D9-Progesterone 324.2319 113.1707 0.047 10 28 6.95 7.6 qualifier 
 
 
The metabolites in each calibrator was made based on levels found in H295R cells and Y1 cells 
when being run with LC-MS/MS method.  
 
Table C 2: Calibrators (standards) in methanol 
 
Metabolites S1 S2 S3 S4 S5 S6 
Cortisol 1.4648 5.8594 23.4375 93.7500 375.0000 1500.0000 
Cortisone 0.4883 1.9531 7.8125 31.2500 125.0000 500.0000 
17-hydroxypregnenolone 0.4883 1.9531 7.8125 31.2500 125.0000 500.0000 
21-OHP 0.1953 0.7813 3.1250 12.5000 50.0000 200.0000 
Corticosterone 0.1953 0.7813 3.1250 12.5000 50.0000 200.0000 
11-DOC 0.0977 0.3906 1.5625 6.2500 25.0000 100.0000 
Testosterone 0.0977 0.3906 1.5625 6.2500 25.0000 100.0000 
Androstenedione 0.2441 0.9766 3.9063 15.6250 62.5000 250.0000 
17OHP 0.4883 1.9531 7.8125 31.2500 125.0000 500.0000 
Progesterone 0.2441 0.9766 3.9063 15.6250 62.5000 250.0000 
Aldosterone 0.0195 0.0781 0.3125 1.2500 5.0000 20.0000 
Estradiol 1.4648 5.8594 23.4375 93.7500 375.0000 1500.0000 
DHEA 1.9531 7.8125 31.2500 125.0000 500.0000 2000.0000 
DHT 0.0977 0.3906 1.5625 6.2500 25.0000 100.0000 
Pregnenolone 0.3906 1.5625 6.2500 25.0000 100.0000 400.0000 
DHEAS 0.4883 1.9531 7.8125 31.2500 125.0000 500.0000 
Estrone sulphate 0.8803 3.5212 14.0847 56.3388 225.3552 901.4206 
Estrone 0.4883 1.9531 7.8125 31.2500 125.0000 500.0000 
Estriol 0.4883 1.9531 7.8125 31.2500 125.0000 500.0000 
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Table C 3: Quality Controls (QC) 
 
Testosterone  
QC Low 0.23 
QC Medium 3.40415094 
QC High 35.8924812 
 
Table C 4: Internal Standard (IS) 
 
Metabolite IS µM (8.5 X final concentration) 
Dehydroepiandrosterone-d4 sulphate 0.2550 
Estrone-d4 sulphate 0.4597 
Aldosterone-d8 0.0102 
Cortisol-d4 0.7650 
11-deoxycortisol-d4 0.0510 
Estrone-d4 0.2550 
Estradiol-d4 0.7650 
Estriol-13C3 0.2550 
Dehydroepiandrosterone-d6 1.0200 
Androstenedion-d7 0.1275 
Testosterone-d3 0.0510 
17-hydroxyprogesterone-13C3 0.2550 
Progesterone-d9 0.1275 
 
 
Table C 5: LC gradient, flow-rate of 400 µl/min 
 
Time (min) % B 
0-0.25 30 
0.25 - 7.75 75 
7.75-10 95 
10-15 30 
 
The following conditions were applied to the ion source (tune page):  
ESI voltages: -2.0 kV (negative mode) or 1.0 kV (positive mode) 
Desolvation temperature: 650°C 
Desolvation gas: 1000 L/h 
Cone gas: 150 L/h 
Nebuliser gas: 7 bar 
Collision gas: argon, 0.5 mL/h 
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APPENDIX D 
These are the results from one 72 hour timeline measurement. Since the 72-hour time line 
required a longer incubation for cells to be in culture, 1.5 mL media was added in each well to 
ensure that the cells had enough nutrients. Even though the 72 hour time line was only done 
once, steroid profiling results showed that the highest levels of pregnenolone and progesterone 
was highest after 30 hours.  
 
Table D 1: Overview of cells and media sampling  
 
 Time points (h) 
Timeline 0 9 12 24 30 48 54 60 72 
 
 
 
 
Figure D 1: Levels of pregnenolone in medium of forskolin stimulated Y1 cells. 
 
 
 
Figure D 2: Levels of progesterone in medium of forskolin stimulated Y1 cells. 
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Figure D 3: Levels of 20α-dihydroxyprogesterone (20αOHP) in medium of forskolin 
stimulated Y1 cells.  
 
 
 
Figure D 4: Levels of corticosterone in medium of forskolin stimulated Y1 cells.  
 
 
Figure D 5: Levels of testosterone in medium of forskolin stimulated Y1 cells. 
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Figure D 6: Levels of androstenedione in medium of forskolin stimulated Y1 cells.  
 
 
 
Figure D 7: Levels of estradiol in medium of forskolin stimulated Y1 cells. 
 
 
 
Figure D 8: Levels of estrone in medium of forskolin stimulated Y1 cells.  
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